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Abstract:
In normal cranial suture development, the cranial sutures close at predetermined periods
of development to allow the brain the capability to grow in a malleable environment. However,
in craniosynostosis, cranial sutures prematurely fuse before birth which can lead to a wide range
of developmental issues and complications. Craniosynostosis can be categorized as
nonsyndromic which involves the sole fusion of one or more of the cranial sutures, or syndromic
in which cranial suture fuse as well as other abnormalities associated with a genetic disorder.
Past research has identified three candidate genes that could be possible disease causing
mutations in nonsyndromic sagittal craniosynostosis. The mutations were found were in ITGAV,
SLC30A9, and BAMBI. Using zebrafish as a model organism, we assessed the phenotypic effects
of mutating itgav, slc30a9, and bambia associated with craniosynostosis. Phenotypic analysis of
heterozygous itgav mutants showed when itgav is mutated there is increased bone formation and
abnormal suture development. Due to the phenotype seen in zebrafish, it is proposed when
mutated, ITGAV can help produce craniosynostosis.
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Chapter 1: Introduction

Craniosynostosis (CS) is the premature fusion of one or more sutures on an infant’s skull.
Throughout the evolution of Homo sapiens, there has been a complex relationship between the
growth of the brain and maternal safety during childbirth.1 The cranial sutures have allowed for
the human brain to expand, while still allowing for a more often than not, safe birth.. These
cartilaginous fibers, the sutures, hold together the different skull bones, and allow the cranium to
be flexible and elastic to allow for the passage of the fetus’ skull through the mother’s birth
canal. The sutures elasticity also allows for skull growth throughout childhood until early
adulthood, as the brain expands. As the sutures allow for this critical brain growth, any
disturbance or interference of properly timed suture fusion could lead to a fetus or child having
serious side effects, such as fatality or brain damage. If the skull bones are prematurely fused,
this can lead to abnormal development, caused by the restriction of brain growth.

Cranial Bone Development
During the first month of development, the human embryo forms all the primary organs
necessary for life. Through the process of gastrulation, there arises three different germ layers
that are responsible for distinct lineages in the body. Two layers, the mesoderm and ectoderm are
critical to generating the skeleton. During days 23-26 of development, some portions of the skull
bones are derived from the mesoectoderm’s neural crest cells and mesoderm through the process
of intramembranous ossification. Intramembranous ossification is the process where
mesenchymal tissue is directly converted into bone, without a cartilage intermediate.2 In this
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process, the cranial neural crest cells multiple rapidly and then condense to form tightly packed
nodules. Part of these cells form capillaries, while the remainder develop into osteoblasts, which
are the precursor to mature bone cells. The osteoblasts are responsible for the release of a
collagen-proteoglycan matrix that allows for calcification through the binding of calcium salts.
It has been hypothesized that bone morphogenetic proteins (BMPs), are responsible for signaling
the neural crest cells to become mature osteocytes.2 In the skull, there are areas between skull
bones that remain undifferentiated. These areas go on to form the cranial sutures, some of which
will not fuse until early adulthood.3
The human skull resembles a complex jigsaw puzzle, compromised of nine cranial bones:
two parietal bones, two frontal bones, two temporal, one ethmoid, one sphenoid, and one
occipital bone. (Figure 1). In between the different cranial bones are the cranial sutures, fibrous
tissues, that function as joints keeping the skull to a limited flexibility. Areas of the skull where
multiple sutures come together are called fontanelles. These fontanelles typically lack bone, and
as such have the appearance of a “soft spot”. The newborn skull has two different fontanelles,
the anterior fontanelle and the posterior fontanelle.3 (Figure 1).
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Figure 1. The lateral and vertex view of anatomical drawings of a newborn skull. Taken
and edited from http://www.nlmnih.gov/medlineplus/ency/imagepages/1127.htm
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Cranial Sutures
There are five main sutures of a human infant’s skull: metopic, lambdoid, coronal,
sagittal, and squamous, shown here in Figures 1 and 2.4 The sagittal suture is the most superior
suture, running parallel between the two parietal bones. The coronal suture, named for
resembling a crown, consists of a left and right suture, running horizontally across the skull
between the frontal and parietal bones. The lambdoid is similarly divided into a left and a right
side, but is located between the supraoccipital and the parietal bones. The metopic suture is
located midline between the two frontal bones. Located at the posterior end of the skull is the
squamous suture, located between the temporal, parietal, and sphenoid bones.3

17

Figure 2. A scan of a 3-D reconstruction of tomography of a 4-week-old patient with normal
suture growth (A-C). Anterior = A, vertex = B, and lateral = C views. Different angles show
different sutures on an infant’s skull. AF = anterior fontanelle, M = metopic suture, S =sagittal
suture, Cor = coronal suture, Sq = squamosal suture, L = Lambdoid suture. Taken from
Beederman, et al. 2014.
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Suture Biology
The first suture to close is the metopic, which typically happens at around 18 months.5 In
contrast, the sagittal suture is the last suture to fuse, fusing around the age of 25 for a typical
adult.3
Throughout development, the cranial sutures fuse when the child’s brain reach key points
of brain growth. During the first two years of childhood development, the brain undergoes an
accelerated period of growth, reaching around 70% of its final weight.6 The brain hits a stagnant
stage, in which brain growth is stalled until early adolescence when the brain grows to its final
adult size.7 Therefore, it is crucial for the sutures to remain open to insure the skull does not
create high intracranial pressure. High intracranial pressure leads to increased pressure on the
brain or spinal cord by pressing against key areas of the brain, causing reduced blood flow and
low oxygen levels in these areas. The lack of critical resources to the brain leads to serious
detrimental effects on a child’s development. Consequences of abnormal brain development,
such as CS, can be or include developmental delay, hydrocephalus, visual impairment, difficulty
breathing, seizures, and in more serious cases, death.8

Syndromic Craniosynostosis
There are different methods to categorize CS: one dividing clinically the syndromic and
nonsyndromic forms. The estimated worldwide prevalence of CS is approximately 1 in 2500
births.9 It is estimated around 25% of all CS cases are considered syndromic. Syndromic CS
occurs when there is premature fusion of the sutures, as well as other bodily abnormalities
commonly seen in an assortment of genetic disorders like Crouzon, Apert, Pfeiffer, and Muenke
syndromes.10 While syndromic CS is rarer then the nonsyndromic form, more is known about
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the genetics of this disorder. Mutations found in genes of the Fibroblast Growth Factor Receptor
family (FGFR), especially Fibroblast Growth Factor Receptor-2 (FGFR2) form a majority of the
known mutations associated with syndromic craniosynostosis.11 Certain genetic disorders like
Apert, Pfeiffer, and Crouzon are associated with mutations in the FGFR family.12 In addition,
the different genetic disorders that cause syndromic CS have different ethnic prevalence
depending the disorder and the population being studied.

Nonsyndromic Craniosynostosis
Nonsyndromic craniosynostosis (NSC) is a condition in which the only clinical feature
observed is the premature fusion of the skull bones. This disorder is the primary focus of this
study. Not much is known about the etiology of NSC, however the disorder is believed to be
caused by genetic and environmental factors. There is currently no evidence to suggest that there
is an altered prevalence found between different ethnic groups and NSC. The vast majority of
cases seen are single suture closures which are classified according to the suture that is
prematurely fused.13 In cases in which one or more of the sutures are prematurely fused at birth,
it is called complex suture synostosis. This happens around 5-15% of nonsyndromic synostosis
cases.5 The phenotype that is produced in complex suture synostosis depends on which sutures
are prematurely fused, and tends to resemble a combination of the different phenotypes seen in
the single suture synostosis forms.10
There are five different types of single suture synostosis, which all result in different
phenotypes. While most cases are suspected to have a genetic basis, no clear pattern of
inheritance has been found. When synostosis is found in multiple family members, the
synostosed suture is typically the same, however there have been cases of different suture
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closures in a family.14 The most common is sagittal synostosis (scaphocephaly), which accounts
for around 45-50% of nonsyndromic cases, with a prevalence of around 1 in 5,000 births.10 The
sagittal synostosis phenotype leads to an unusually long and narrow skull resembling a boat’s
keel, which led to its name “scapho” or boat in Greek. (Figure 3a). On average, male subjects are
more prone than females to develop sagittal synostosis by a 3.5/1 ratio.15 The condition is largely
sporadic, however there has been some evidence to show familial transmission in (NSC), as a
dominant mode of transmission in 2-6% of cases observed.16 Certain risk factors have been
suggested to contribute to NSC such as advanced maternal age, twinning, maternal smoking, and
intrauterine head constraint.14
The second most commonly observed single suture synostosis is coronal synostosis, also
known as anterior plagiocephaly. There are two types of coronal synostosis, unicoronal where
one of the sutures is closed, and bicoronal where both are fused. Unicoronal synostosis is more
prevalent then bicoronal, and typically results in one side of the skull being raised, leading to an
asymmetric skull shape. Coronal synostosis accounts for around 25-30% of all NSC cases and is
found to be more prevalent in females than males with a 1:2.3 ratio.13 Some evidence suggests
that advanced paternal age is a risk factor for the disorder.17 The anterior plagiocephaly
phenotype is defined as a flattening of the forehead on the side of the coronal synostosis, which
commonly causes the skull to appear asymmetrical, as well as having a protruding eye socket or
irregular nose.18 (Figure 3b).
The third most common type of NSC is the metopic synostosis or trigonocephaly from
the triangular protrusion in the forehead produced by the synostosis. A typical phenotype
resembles a pointed forehead with pinched eyebrows. (Figure 3c). This synostosis, cases of
which have been on the rise, accounts for around 14% of cases seen. Males are affected more so
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than females with a ratio of 3.3:1.10 Advanced maternal age, as well as a low birth rate have been
associated with an increased risk of the synostosis.19 Due to the metopic suture being the first
suture to fuse at 8 months, a cranioplasty must be performed within one year of birth to decrease
the chance of neurodevelopmental delays.19
The least common of all NSC cases are lambdoid synostosis or posterior plagiocephaly
and are responsible for 3% of cases. Unlike the other synostoses, no specific genes have been
identified in this synostosis, however chromosomal rearrangements have been suggested.20 The
posterior portion of the skull is affected in this synostosis, with occipital dysmorphism that
entails a mastoid bulge as well as a thickened ridge around the affected suture.18 (Figure 3d).
Intrauterine constraint, preterm labor, and male gender have all been associated with an
increased risk of lambdoid synostosis.21
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Figure 3. Visual representation of different types of synostoses. (A) A
vertex and lateral view of sagittal craniosynostosis. (B) Anterior and vertex
view of left coronal craniosynostosis. (C) Anterior and vertex view of metopic
craniosynostosis. (D) Anterior and posterior view of left lambdoid
craniosynostosis. Taken from Ciurea, et al and Pincus, et al.
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Treatment Options
It is unknown what causes NSC, and as such there is no preventive measure that can be
taken for the disorder. This means that physicians can only treat the disorder once it has already
occurred. When CS is a likely diagnosis, a physical examination occurs that assesses the
craniofacial shape, the movement or lack of movement of the calvarial bones during infancy, and
the presence/lack of sutural ridging.14 Computed tomography (CT) is also used to get a clear
image of the underlying cranial structures, and 3-D CTs are an invaluable, preoperative tool for
future cranial surgical corrections.22 (Figure 4). While there are some cases in which a
specialized, molded helmet can be used to help correct the shape of the skull, most cases require
more invasive measures. Surgical intervention is the typical method to relieve intracranial
pressure on the brain. The surgery takes place in an affected child’s first year of life with timing
being vital, it takes places as soon as the child can withstand the stress of the surgery.18 The aim
of the surgery is to separate the fused sutures to lessen the intracranial pressure on the infant and
allow for the normal development of the skull. The surgery is intense and requires multiple
specialties such as neurosurgery, plastic surgery, occuloplastics, and neck specialties in order to
be successful.8
The cranial surgery is not without risks, and there are numerous, severe complications
that can occur, like bleeding, infection, cerebrospinal fluid leakage, meningitis, stroke, and death.
The period between the ages of 6 and 12 months is recommended by surgeons, as previous
research has indicated that surgery before 6 months of age leads to a less successful outcome
with an increased risk of an additional operation. Due to the severe invasiveness of the surgery,
current research has focused on prying apart the genetic basis of NSC. It is the goal to be able to
eventually provide earlier and targeted interventions as well as developing specific gene therapy
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for the prevention of premature suture fusion.18 This would eliminate the severe stress of a
complicated surgery as well as drastically reduce the risks associated with the surgical
intervention treatment.
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Figure 4. Image of the 3-D technology available to diagnose and treat craniosynostosis. On
the left, a computed tomography-scan of a 5 month old child who has trigonocephaly. On the
right, the same child with a 3-D computed tomography scan. Taken from Ursitti, et al. 2011.
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Genetics of Nonsyndromic Craniosynostosis
NCS has been suggested to have genetic causes, due to a high recurrence risk seen in
affected families, as well as a higher concordance rate in monozygotic twins, than dizygotic.17
There is evidence that suggest sagittal synostosis has a dominant form of inheritance in 7% of
familial cases.16 This suggests that there is a genetic component to the disorder, and the
inheritance is likely to be complex. There is no clear genetic cause of the various NSC
premature fusions, however a few sagittal synostosis causative mutations have been identified. A
clear case of epistatic interaction between mutated SMAD6 (SMAD family member 6 ) and a
common SNP in BMP2 has shown that sagittal synostosis is produced when these two genes
variants interact.23 As sagittal synostosis is the most common form of NSC, it is hypothesized
that there are various genes that could be causing the phenotype.
In addition there have been studies undertaken in coronal synostosis that have indicated a genetic
component to the phenotype.24 There are currently five different genes that are associated with
NSC, which will be discussed in length.

Fibroblast growth factor receptor 3 (FGFR3) – Coronal Synostosis
The genes in the FGFR family have previously been associated with syndromic
craniosynostosis. However isolated coronal synostosis has been found to be associated with a
mutation in FGFR3 that changes a proline to an argentine (P250R). This was found by whole
exome sequencing of DNA of affected individuals with unicoronal coronal synostosis, and
researchers then sequenced affected individuals and their families looking to see if this candidate
mutation was seen in others. It is rare to see a familial aggregation in NSC, however a follow-up
study showed that 4 out of 37 individuals with isolated coronal synostosis had the mutation.24 In
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this study 3 of the 4 individuals affected with coronal synostosis shared the same father who also
had the mutation but was not affected, which raises the possibility of reduced penetrance of the
mutation.24 A follow up study performed on 76 unrelated individuals with isolated coronal
synostosis showed that 29 had the same FGFR3 P250R mutation.25 The mutation is also
associated with an increased risk of a transcranial reoperation rate. These studies have led to the
conclusion that FGFR-related mutations tend to present a specific NSC phenotype, coronal
synostosis.

FRAS1-related extracellular matrix 1 (FREM1) – Metopic Synostosis
Nonsyndromic metopic synostosis has been found to be associated with FREM1. FREM1
is a gene responsible for an extracellular matrix protein, FRAS1 (Fraser syndrome 1 homolog)
related extracellular matrix 1 that plays several key roles in the body. FRAS1 is responsible for
regulating epidermal-basement membrane adhesion and organogenesis. It also helps to stimulate
epidermal differentiation, as well as craniofacial and renal development.26 In one study of 109
individuals affected with nonsyndromic metopic synostosis, there were 5 de novo copy number
variants found as well as three missense mutations in FREM1 exons.27
Using mouse models, it was found that FREM1 produces a protein that is expressed in the
posterior frontal suture, the mouse equivalent of the metopic suture.27 When loss of function
mutations of FREM1 were introduced into two different mouse lines, premature fusion of the
posterior frontal suture occurred.27
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Bone Morphogenetic Protein-2 (BMP2)-Sagittal Synostosis
In NSC, sagittal synostosis is the most common form of the disorder. The first genomewide association study (GWAS) into sagittal synostosis was performed using 130 parental trios
of European descent. An additional study was performed with 172 unrelated probands and 548
controls. An association with NSC was found with the BMP2 SNP, rs1884302.28 This gene
plays a role in encoding a ligand of the TGF-b pathway, which leads to the recruitment and
activation of the family of transcription factors, SMADs. Functions of BMP2 include a role in
bone and cartilage development, which suggests further studies in the role it plays in NSC.

Bardet-Beidl Syndrome 9- (BBS9)- Sagittal Synostosis
In the previously mentioned GWAS study above, an association was also made with the
BBS9 SNP, rs10262454.28 This gene has not been found in any NSC studies, however it has
been found to be involved in parathyroid hormone action in bones. While the exact function that
this genes plays is not known, due to its strong association with sagittal synostosis as well as the
synostosis complex inheritance, further studies will more than likely consider its role.

SMAD family member 6 (SMAD6) and BMP2– Sagittal Synostosis
SMAD proteins serve as signal transducers and transcriptional modulators that help
regulate a multitude of different signaling pathways. Of relevance to NSC is SMAD6 and its
ability to negatively regulate BMP and the TGF-b signaling pathways. SMAD6 had been shown
to be induced by BMP2 as well as playing a role in chondrocyte differentiation.29 A recent study
has identified rare variants in SMAD6 that when paired with a common risk allele of the
rs1884302 SNP in BMP2 causes NSC. The study found through exome sequencing of 191
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infants with sagittal synostosis that de novo or rare mutations in SMAD6 when paired with a
common variant in BMP2 causes sagittal synostosis. The common variant in BMP2 that confers
risk of CS can either be C or a T. The C allele confers risk of CS to an individual. There were
13 predicted damaging variants in SMAD6 and 8 of these were frameshift, which indicates that
haploinsufficiency in SMAD6 contributes to the phenotype.30 The study found those with only a
SMAD6 mutation had around a 9% risk of synostosis, but when paired with the common risk
allele in BMP2 there was a 100% chance of sagittal synostosis.30 This shows that there is
epistatic interaction between rare mutations in one locus with a common variant at another,
unlinked locus, which has broad implications for future research and diagnosis of NSC.

Using Zebrafish as a Model Organism
The zebrafish (Danio rerio) is an ideal model organism to use to study CS. Zebrafish are
small, freshwater cyprinid fish with approximately 70% orthologues to human protein coding
genes and 84% of genes known to be associated with human disorder.31 This high degree of
similarity makes them a valuable research model to understand which genes play a role in human
health and disease. Perhaps the most powerful aspect of zebrafish as a model organism is the
ability to study vertebrate embryogenesis, morphogenesis, and gene function due to the
zebrafish’s natural development ex utero.32 The zebrafish embryos allow for a high degree of
visibility, which allows for analysis through early embryonic development. Zebrafish have a
high fecundity, which allows for quick genetic analysis and allows for an increased sample size
when running statistic tests.
The skull of a zebrafish are made up of a variety of bones, that have two main origins, the
neural crest or mesoderm.33 The zebrafish skull has three pairs of cranial skull bones, the frontal,
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parietal, and occipital that are similar to humans. (Figure 5). Zebrafish have four cranial sutures,
the interfrontal, sagittal, coronal, and lambdoid which are also like those in humans. Also
similar is the intramembranous ossification that occurs in the skull, where the frontal bones are
formed by neural crest cells and the parietal bones developing from the mesoderm. A key
difference in zebrafish compared to humans is that the anterior suture of the zebrafish skull never
fuses shut.34 The craniofacial region is easily visible in both juvenile and adults as the skull is
encased in only a thin layer of tissue. Bone formation or osteogenesis, is first detectable around
27 days post fertilization (dpf). The process begins at the frontal bone and spreads to cover the
whole skull typically by day 51. As early as day 21, the beginnings of the cranial sutures are
detectable as evident by Figure 6. It is also essential to note that due to the variable rate at which
zebrafish grow, age is not an accurate way of detecting when bone formation and suture
development begin. Due to different environmental factors influencing zebrafish growth,
standard length measurement in millimeters is used to dictate developmental checkpoints for the
skull. It should be noted in zebrafish, the cranial suture formation is an independent process
from the osteogenesis, which is why it is detectable before the beginning stages of
osteogenesis.32
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Figure 5. Development of the zebrafish skull vault over time. Skulls were dissected
from the larvae, juvenile, and adult zebrafish and assessed with a stereomicroscope.
Cranial sutures are designated by arrows and labeled frontal bone (F), parietal bone (P),
supraocciptital bone (Soc). Taken from Quarto, et al. 2005.
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Figure 6. Development of the cranial skull in zebrafish. Zebrafish were fixed in 4%
paraformaldehyde and Alizarin Red was used to detect formation of bone development.
Beginning at 27 dpf, ossification (black arrow) starts from the anterior portion of the skull (frontal
bone). Ossification is typically completed by 51 dpf. Taken from Quarto, et al. 2005.
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Patients
Individuals with CS were first assessed by Dr. Jennifer Rhodes, at the Virginia
Commonwealth University Center for Craniofacial Care. Blood samples were taken from each
patient, and additional samples were taken from family members that consented. One family, a
trio had an affected father (CS-65), unaffected mother (CS-66), and an affected daughter (CS64). The daughter was born with sagittal synostosis, and her father (CS-65) based on a clinical
assessment, had sagittal synostosis as well. This CS-64 family, provided the basis of our
candidate gene study, as three different candidate genes were identified. A pair of monozygotic
twins, CS-14 and CS-15 discordant for sagittal CS was also included in the study. CS-14 is
affected with nonsyndromic sagittal CS, while CS-15 is not. Genetic screening was performed on
the twins, indicating a possible candidate gene in SPRY1. Both twins have the variant, however
it didn’t segregate clearly with the synostosis phenotype seen. The final family analyzed was a
family of six individuals, including an unaffected mother (CS-7), unaffected father (CS-2), and
four of their children (CS-3, CS-4, CS-5, CS-6). CS-3 and CS-4 were born with sagittal
synostosis. CS-5 was born with midline cutaneous meningioma, but did not present with a
craniosynostosis phenotype. CS-6 is unaffected. Genetic screening was performed and
identification of a possible candidate gene was found in SMURF1. However, there was no
segregation of the SMURF1 variant that explains the synostosis phenotype found in the family.

Selection of Candidate Genes for Study
Previous work in the Shiang Lab sought to identify possible causes of CS through a
genetic analysis of several affected individuals and their families. Whole exome sequencing of
each affected individual’s genomes allowed a multitude of candidate genes to be identified. The
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next stage was to identify causual variants. KGGseq was used, which performed a three-level
filtration framework to sort through the variants. The first level of filtration is at the genetic
level, which acts to sort out mutations that do not segregate with the phenotype. The second
level of filtration is at the variant-gene level, which then analyzes each variant found and filters
out common variants. The final level of filtration is the knowledge level, which uses known
protein-protein interactions taken from the STRING database to predict which variants are the
most deleterious. The information found in KGGseq was then analyzed using the Integrated
Genome Viewer, which allowed for variants to be individually analyzed. One family was found
to have candidate mutations, and these variants were assessed using Project HOPE. Project
HOPE can build a protein structural model, to determine the domains and motifs found within
the proteins structure. This information can be combined to predict the effect the candidate
mutations will have on protein structure and stability. In total, three variants were selected from
CS-64 family, in which the daughter and father presented with sagittal synostosis. Of families
with no good candidate variants segregating with the disorder, rare deleterious variants were
screened in putative candidate CS genes which identified the SMURF1 and SPRY1 variants
discussed above.

Candidate Gene Identification from CS-64
As previously stated, CS-64 was a female patient affected with non-syndromic
craniosynostosis. Her father was also affected; and a genetic analysis was performed. When
CS-64 was sequenced, a variety of different candidate genes were found and then underwent a
stringent filtering process via functional prediction and protein stability prediction. Two genes,
integrin subunit alpha V (ITGAV) and solute carrier family 30 member 9 (SLC30A9) stood out as
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candidates to knockout. Another gene, BMP and activin membrane bound inhibitor (BAMBI),
became a focus for an overexpression study. In ITGAV, the is in a mutation in a region of
repeats called “FG-GAP 1”, that changes a leucine to a phenylalanine. This region is critical as
it is found in an area that controls ligand binding, due to its location in the N terminus of integrin
alpha chains. The phenylalanine instead of a leucine mutation is predicted to interfere with the
string of repeats, causing the protein to be destabilized due to the evolutionary conserved nature
of amino acids. SLC30A9 was found to have a proline instead of a leucine mutation that is
predicted to disrupt its transmembrane domain. It is thought that this protein functions as a zinc
transporter, and the mutated version of SLC30A9 disrupts the normal flexibility and stability of
the wildtype protein. This mutated form is thought to damage protein structure and cause a
decrease in the protein’s stability and function. BAMBI encodes a protein that serves as a
pseudoreceptor. The mutation found in family CS-64 is a valine instead of methionine mutation
found in a conserved domain. Based on protein prediction algorithms, it is predicted that this
mutation increases the stability of the protein. These genes, ITGAV, SLC30A9, BAMBI, will now
be discussed at length.

ITGAV
The bridge that binds the extracellular matrix to the cell are the integrins. These receptors
bind the matrix to the cell’s cytoskeleton allowing for a wide variety of cellular activities, such
as extracellular matrix-mediated cell adhesion, migration, cytoskeletal organization, cell
proliferation, survival, and differentiation. Integrins are composed of heterodimers, consisting of
glycoprotein subunits, named alpha and beta. There are 24 alpha genes and 9 beta genes, which
when paired with alternative splicing results in a wide range of variability seen among integrins.

36

These subunits dimerize and bind ligands to allow for cellular communication. Extracellular Ca2
or Mg2+ is needed for integrins to successfully bind with ligands.35
Once the integrin has bound the ligand, the beta subunit’s cytoplasmic tail binds to
additional intracellular anchor proteins, like talin, a-actinin, and filamin. These intracellular
anchor proteins allow for additional binding to occur to actin or to another anchor protein,
vinculin, which helps the integrin link up to actin filaments found in the cell cortex. These
multiple binding properties of integrins also allow them a role in cellular signaling. Through the
binding of talin to the b subunit or paxillin to the a subunit, a cytoplasmic protein tyrosine
kinase called focal adhesion kinase (FAK) is recruited. FAK is one of the major players in
tyrosine-phosphorylation signaling. Integrins cluster at sites of cell-matrix contact, which brings
FAK into the clusters where they can cross-phosphorylate one another.35 This clustering and
cross-phosphorylation creates a phosphotyrosine docking site for members of the cytoplasmic
tyrosine kinases.35 This interaction allows Src to phosphorylate p130CAS and paxillin, which
turns on the Crk-DOCK180 complex to activate Rac. Rac in turn activates p21-activated kinase
(PAK), Jun amino-terminal kinase (JNK), and nuclear factor kB (NF-kB). In addition, FAK,
when paired with Crk-DOCK180 complex, turns on extracellular signal-regulated kinase
(ERK/mitogen-activated protein kinase (MAPK)). FAK also plays a role in recruiting growthfactor-receptor-bound 2 (GRB2) and son-of-sevenless (SOS) complex to activate the
ERK/MAPK pathway.36 (Figure 8).
ITGAV is located on chromosome 2q32.1in humans, and encodes the light and heavy
chains that make up the alpha V subunit. This specific subunit has been found to interact with
beta 1, beta 3, beta 5, beta 6, and beta 8 subunits. av integrins are found in multiple cell types,
and play a role in development depending on which b subunit has bound. Expression in humans
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has been shown to be high in the thyroid, ovaries, heart, and kidneys. ITGAV has been implicated
in having roles regulating angiogenesis, cancer progression, cellular proliferation, cellular
differentiation, and osteoblast differentiation. Of interest is to note that BMP2 upregulates the
expression of ITGAV, and ITGAV plays a crucial role in BMP2’s function in osteoblasts.37
A study of an Itgav knockout mice, showed that 80% of homozygous Itgav mice die
during development, while 20% survive until birth. Of the 80% that die, it is suggested that this
is due to placental defects. The 20% that did survive birth suffered from intracranial and
intestinal hemorrhage and cleft palate and died shortly after birth.38 In response to these mouse
studies, zebrafish morpholino antisense oligonucleotides were produced that knocked down
itgav. The morpholino studies showed that itgav played a part in vascular stability, vertebrate
trunk elongation, and gastrulation movements that regulate vertebrate body symmetry.39

38

Figure 7. The many pathways of integrin signaling. Taken from Guo, et al. 2004.
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SLC30A9
The SLC30A9 gene in humans codes for member 9 in a family of zinc transporters
(SLC30) that regulate zinc homeostasis within the cell. (Figure 9). Zinc is a biological necessity
for a multitude of enzymes, due to its ability to act as a cofactor. Zinc also plays a critical role in
fetal development and maternal zinc deficiency in mammalian models have led to numerous
birth defects.40 There are multiple genes that regulate zinc transport, however the SLC30 (codes
for ZnT proteins) family of genes’ main role is to promote the shuttling of zinc from the cytosol
to various destinations, including out of the cell to avoid zinc toxicity or when zinc levels are
high, into the lumen of vesicles or different organelles. Zinc transporters are important in the
cell for a wide range of functions, such as cellular growth, development, reproduction, immunity,
and bone formation.41
The structure of the ZnT family typically are made up of 6 transmembrane domains, with
long C-terminal tails. The region between domains IV and V is particularly important, as there is
a large histidine/serine prevalent loop, to which zinc binds. The biggest difference between
members is the protein length and the amino acid sequence upstream of the first TM domain
which code for different subcellular targeting signals.42 ZnT-9, like the vast majority of its
family members, with the exception of member 5 functions as a homodimer.43
The role of SLC30A9 is not very well documented, however some members of its family
can provide clues to its function. SLC30A7, when inhibited, has been shown to increase the
amount of osteogenic differentiation of mesenchymal stem cells. When SLC30A7 is
overexpressed, there is a down-regulation of beta-catenin. The role of beta-catenin is important
in its interactions with the Wnt genes, to activate differentiation of mesenchymal stem cells. The
closely related family member, SLC30A6 has been shown to be expressed throughout the body,
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but is found predominantly in the brain, lung, and intestine and on a subcellular level in the
membrane of the Golgi apparatus. Interestingly, ZnT-6 has been shown to have an increased
expression in Alzheimer’s disease, which suggests it could be contributing to the pathology of
the preclinical stage of Alzheimer’s.44
ZnT-9 has been found in the cytoplasm, as well as in the nucleus (Figure 10). This
makes it unique among its siblings in the ZnT family as it is the only family member that resides
in the cytosol and can ferry into the nucleus once it is bound to a nuclear receptor or transcription
factor, to regulate gene expression. ZnT-9 is shown to be a coactivator of nuclear receptors.45
The role of ZnT-9 as a transcriptional coactivator has not been completely characterized,
however it has been proposed to work as a chaperone protein that delivers zinc ions to
transcription complexes in a target gene’s promoter region to increase transcriptional activity.42
In zebrafish, zinc is required for many biological processes, and they have remarkably
similar proteins to humans that regulate zinc homeostasis.46 Studies of the zebrafish ortholog
slc30a9 have been undertaken, largely to understand the role that zinc plays in early embryonic
development. As zebrafish develop externally, the embryos are ideal to understand the impact
zinc has on development. One study sought to profile the mRNA expression of all known zinc
transporter genes in the zebrafish throughout various critical periods of development. SLC30A9
was found to be expressed in low levels in the early stages of embryonic development, yet a
fivefold increase occurs at 120 hpf. (Figure 11).
While the function of SLC30A9 in humans and zebrafish is still not well known, this gene
is of interest to our study due to its unusual location in zinc transport and the important roles of
other SLC30 family members.
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Figure 8. The evolutionary relationship between members of the SLC30
family of zinc transporters genes. Purple lines indicate subfamily I. Green
indicates subfamily II. Blue indicates subfamily III. Red indicates subfamily IV.
Taken from Huang, et al. 2013.
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Figure 9. Diagram of the cellular location of the members of the Znt family. Taken from
Huang, et al. 2013.
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Figure 10. Representation of mRNA abundance profiles of the ZnT family expressed in
zebrafish embryos throughout early stages of development. Taken from Ho, et al. 2013.
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BAMBI
In humans, the BAMBI gene is located on chromosome 10p12.1, and has three exons.
The gene codes for a transmembrane glycoprotein that is related to the type I family
transforming growth factor-beta (TGF-b) receptors. The TGF-b receptor family is involved in
many developmental and pathological processes, with its role of signal transduction. However,
BAMBI differs from this family as it encodes a protein that acts as a pseudoreceptor, which lacks
the necessary intracellular serine/threonine kinase domains required for signaling. While the full
functionality of the gene is still not known, the protein acts as a negative regulator of TGF-beta,
to limit the signaling range of the TGF-beta family during early embryonic development.47
BAMBI has been shown to be induced by BMP signaling through the BMP-responsive
elements in its promoters well as directly induced by TGF-b signaling thanks to its three tandem
repeats of 13 base pair sequences that contain SMAD3 and SMAD4 binding elements.48 These
sequences that contain SMAD-binding elements are different from the BMP-responsive
elements.48 Due to the significance of TGF-b signaling in anti-proliferation properties of cells,
genes that inhibit TGF-b signaling have been found to be up-regulated in a variety of cancers.
BAMBI has been found to be overexpressed in most colorectal, hepatocellular, and ovarian
carcinomas .49,48 In addition BAMBI has been shown to work with SMAD7 in inhibiting TGF-b
signaling, leading to increased tumor invasion and metastasis in gastric cancer.45
BAMBI has also been found to play a role in Wnt/b-catenin signaling, which plays a
crucial role in regulating embryonic development as well as tumorigenesis. When BAMBI is
overexpressed this increases the expression of Wnt-responsive reporters, while knockdown
decreases them. It has also been found to interact with key components of Wnt signaling, by
promoting the interactions between several key genes. BAMBI has also been found to enhance
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cyclin D1 and c-myc expression and when BAMBI is overexpressed, helps transition the cell
cycle from G1 to S phase.50
BAMBI has been shown to negatively regulate adipogenesis and modulate the anti-and
pro-adipogenic effects of the Wnt, TGF-b, and BMP4 pathways, leading to potential therapeutic
targets in fighting against obesity in type 2 diabetes.47
In zebrafish, bambia has been found with bigh 3 to be up-regulated in the process of fin
regeneration between the days three and five post-amputation.51 While not much is known about
the complete role of BAMBI in the body, due to its importance in TGF-b and Wnt signaling, it is
a gene of interest in our study.

Aims:
The goal of this study is to analyze several candidate genes to see if they play a role in
NCS. The first aim is to evaluate two SNPs associated with NSC to see if these variants
contribute to NSC in our families.
Wildtype zebrafish will be tested in the second aim to determine if the candidate genes of
interest are expressed in the skull at various time points in development, in order to test their
relevance in synostosis.
Lastly, genetically modified zebrafish lines will be produced to test whether three
candidate genes in family CS-64 produce a synostosis phenotype.
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Chapter 2: Materials and Methods

Genotyping for the BMP2 risk allele rs1884302 and Bardet-Biedl syndrome 9 (BBS9) risk
allele rs10262453
The BMP2 risk allele, rs1884302 is a single nucleotide polymorphism (SNP) that can
either be a T or a C. When genotyping this risk allele, a PCR and a restriction enzyme digest
was used. The PCR reaction consisted of 5 µl 1X Gotaq Green (Promega), 3 µl of ddH20, and 1
µl each of forward and reverse primer (100 pmol/µl) to produce a final volume of 10 µl, with 1
µl of the DNA template (<100 ng) added.. (Table 1). The PCR product was digested with EcoRI
(NEB). A 12.5 µl reaction was used and contained 8.7 µl of H20, 1 µl of 10X 2.1 buffer (NEB ),
0.3 µl of EcoRI (20,000 U/ml), and 2.5 µl of the PCR product. Digests were run at 37°C
overnight using a thermal cycler. The size of the PCR product was 220 base pairs and were run
on 2% agarose gels. DNA was visualized by ethidium bromide (EtBr) and was imaged using
Alpha Imager. If the enzyme cuts the digest product at 128 bp and 92 bp, which indicates there is
a C allele at the SNP, which has been associated with NSC. If there is no cut, then this means
there is a T allele and no risk has been found to be associated with it.
The BBS9 risk allele rs10262453 is a single nucleotide polymorphism (SNP) that can
either be an A or a C. A PCR was performed using the of DNA (<100 ng), 5 µl of 1X Gotaq
Green (Promega), 3 µl of H20, and 1 µl of each the forward and reverse primer (100 pmol/ul)
(Table 1). There is not a restriction enzyme that we could use to genotype the SNP, so we
decided to use heteroduplex analysis to visualize any sequence difference(see below). This
allowed us to check which BBS9 samples were homozygous and which were heterozygous.
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Primers were made according to Timberlake, et al. 2016 30 (Table 1). Before loading the PCR
product onto the gel, 2.5 µl of loading dye was added.

Heteroduplex Analysis
Heteroduplex analysis were performed to check for mutations caused by the CRISPR
injections as well as to genotype for the BBS9 risk allele in CS patients. After running a PCR
with the samples, the samples were denatured and slowly annealed by placing in a thermal cycler
programmed to run at 95° C for 10 minutes, 85° C for 1 minute, 75° C for 1 minute, 65° C for 1
minute, 55° C for 1 minute, 45° C for 1 minute, 35° C for 1 minute, 25° C for 1 minute. The
samples were then placed in a 20° C water bath for 40 minutes. A 7.1% acrylamide gel was then
made from 7 mls of 49:1 ratio of acrylamide/bisulfate acrylamide (50% stock solution), 8.4 mls
5x TBE buffer, and 7 mls glycerol, 312 µls of 10% APS, and 46 µls of TEMED. Once the gel
was poured, samples were loaded and then run for 28 hours at 60 V. All gels are then stained in
EtBr for five minutes and then visualized using the Alpha Imager. If there is one band at 162
base pairs the sample is homozygous for either a C or an A allele. Two bands, one at the 162
region and the other directly above it, signal that the sample is heterozygous and contains both a
C and an A allele.

Table 1. Primers used for NSC Associated SNPs.
Primers Forward Primer

BMP2
BBS9

GGTGGAAGGTGAAGGGTCCC

Reverse Primer

GAGTGAGAATA
TAAGTATTCC
CCCAAACCTAGGCCTCAGTCCTATCC GCCCACTGGTTT
GTTACCTTG

Annealing
Temperature
(°C) X cycles
58x30
56x30
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Zebrafish Culture and Maintenance,
Adult fish are kept at approximately 28°C on a 14 hour/10 light/dark cycle. All fish that
were used for experiments were of the wildtype strain (AB/WIK or ZIRC AB) unless they were
otherwise indicated. Embryos were kept at a stable 28°C and raised to five days post fertilization
and then transferred into tanks.52

Formation of CRISPR/Cas9 Clone Generation
A primary aim of this project was to create knockout lines of itgav and slc30a9. To do
this, CRISPR/Cas9 guides had to be created. To obtain targets for CRISPR,
https://chopchop.rc.fas.harvard.edu/ was used. The CRISPR guide RNAs (gRNA) were created
based off the protocol from Talbot and Amacher.53 Three different gRNAs were designed for
itgav (itgav guide 1, 2, and 3) as well as slc30a9 (slc30a9 guide 1, 2, and 3) produced and used
for injections. Multiple guides were designed as there is an approximately 50% success rate for
each guide. Each guide consisted of a clamp, T7 promoter, target sequence, and an overlap with
the guide constant oligo. IDT provided all gRNAs, gRNA Primer 1, gRNA Primer 2, and guide
constant oligo and primer sequences are shown in the Table 2.
The template oligos were amplified using the same protocol from Talbot and Amacher.53
The PCR reaction consisted of 1x Themopol buffer, 0.25 µM for both gRNA Primers 1 and 2,
0.02 µM short-guide oligo, 0.02 µM guide constant oligo, 3% DMSO, 0.2 mM dNTPS, and 1.5
units Phire Hotstart II DNA Polymerase (Thermo Scientific) for a total of 50 µl reactions.
Reactions were amplified with a 60°C annealing temperature for 40 cycles. The PCR products
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were visualized on a 6% acrylamide (19:1)/10% glycerol gels in 0.5X TBE, with EtBr as a
staining agent.
An Ambion MEGAScript Sp6/T7 kit was used for transcription of the gRNA following
manufacturer’s instructions, after transcription the product was cleaned using the MirVana
miRNA Isolation Kit. Each gRNA was then diluted to 200 ng/µl for use in injections.

Table 2. Sequences for CRISPR/Cas9 primers.
Name

Sequence

SLC30
A9
Guide 1

GCGTAATACGACTCACTATAGGTGCAGGTAGACCCGGCAGGTTTTAGAGCT
AGAAATAGC

SlC30A
9
Guide 2
SLC30
A9
Guide 3

GCGTAATACGACTCACTATAGGCAGGTATCAGCCAACGAGGTTTTAGAGCT
AGAAATAGC

ITGAV
Guide 1

GCGTAATACGACTCACTATAGGCCCCAGAGGAACGCACAGGTTTTAGAGCT
AGAAATAGC

ITGAV
Guide 2

GCGTAATACGACTCACTATAGGGGCTCAGATGGCAAACTGGTTTTAGAGCT
AGAAATAGC

ITGAV
Guide 3

GCGTAATACGACTCACTATAGGTTCATCGCAGAGACCTGGGTTTTAGAGCT
AGAAATAGC

Guide
Constant
Oligo

AAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACG
GACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC

gRNA
primer 1
gRNA
primer 2

GCGTAATACGACTCACTATAG

GCGTAATACGACTCACTATAGGAGGACTGACCTGACAGCGGTTTTAGAGCT
AGAAATAGC

AAAGCACCGACTCGGTGCCAC

Table 2 Key: Red indicates the clamp sequence, grey is the T7 promoter, black shows the target
sequence, and green is where an overlap with the guide constant occurs.
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Zebrafish Injection
The injection trays were made with agarose (0.45 grams) that were mixed with 30 mls of
the filtered system water, making a 1.5% agarose injection tray. The mix was microwaved for a
minute to melt the agarose and then allowed to cool at room temperature for ten minutes. Thirty
microliters of Methylene blue were then added to the solution, swirled to mix, and then poured
into a petri dish. After pouring, an injection tray mold was set on top of the fluid as it solidified.
Until use, the trays were stored at 4° C, and wrapped in plastic wrap. The Sutter P-97
Flaming/Brown micropipette puller on program 6 was used to create the needles used for
injections. The parameters for this program are heat (50), pull (100), velocity (150), and time
(100 mSec).
To obtain embryos for the day of the injection, zebrafish males and females were put into
pairs in spawning tanks overnight. The next morning, the fish pairs were placed in a new
spawning cage filled with new system water and the divider separating the two was removed.
The cage was then slightly tilted allowing for an incline in the cage’s water level to allow
increased chances of a successful mating. This is due to the natural mating habits of zebrafish,
which spawn in shallow waters. By giving the fish an incline, it seeks to replicate their natural
habit. Blinders are then placed around the cage to keep the fish focused. Once eggs are
fertilized, the injections take place ten minutes afterwards. There were six guides in total, three
different guides for both itgav and slc30a9. For each guide, approximately 40 embryos were
injected. A mixture of 200 ng/ul of each RNA CRISPR guide was mixed with 200 ng/ul of the
Cas9 mRNA to give a final concentration of 100 ng/ul of each. Approximately 1 nl of the
mixture was then injected into the individual embryos. Uninjected control wildtype were used
and approximately 40 were raised up.
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Genotyping Zebrafish
To check if mutations were obtained, DNA was prepared from eight individual embryos
for each guide. DNA was prepared according to MEEKER et al.54. Embryos were euthanized
and then placed in a tube containing 47.6 µl of water and 2.4 µl of 1 M NaOH. After ten minutes
at 95° C, 5 µl of 1 M Tris-HCL, pH 8.3 was added. Tubes were then spun in a microcentrifuge
at 10,000Xg and stored at -20° C.
Genotyping was performed using PCR and heteroduplex analysis (see above) to confirm
CRISPR had caused mutations to occur. PCR amplification was performed at specific annealing
temperatures for each primer set (Table 3 and 4). Each tube received 5 µl of 1X Gotaq Green
(Promega), 3 µl of RNase free water, 1 µl of the forward primer (10 pmol/µl), one µl of the
reverse primer (10 pmol/µl), and 1 µl of DNA.

Table 3. Primer information for PCR reactions for fish lines.
Forward Primer
Reverse Primer
itgav Guide 1
GATGACAGAAAGCATTCCAATG GCAGATGTTTTTATTCAGGT
itgav Guide 2
TGTTCAGAAAGACCTGCATCAT CGGTGAGTTTCATCACACTGTT
itgav Guide 3
GAGTCCCACATTTCTTGACCAG ATGCTGGTCTTTTTCTAAAGCA
slc30a9 Guide
1
slc30a9 Guide
2
slc30a9 Guide
3

GTGGACAGTCACATGACCAGTT

TTCACACGACAGATGGAAATC

ACTGACCCACTTTTTGAACAC

CTCTTGACCACCCCTTACACAT

TCTCGGTGTAGGCACTCTGTTA

TTTGACAAGCATTTGTACAGGG
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Table 4. Annealing Temperatures and cycle number for PCR reactions.
Guide
Product Size
Annealing Temperaturen (°C)
and Cyle Number
itgav guide 1
60 x 40
170 bp
itgav guide 2
60 x 40
288 bp
itgav guide 3
55 x 40
251 bp
slc30a9 guide 1
55 x 30
281 bp
slc30a9 guide 2
55 x 40
253 bp
slc30a9 guide 3
57 x 30
255 bp

Genotyping for Germline Transmission
Injected embryos were raised in an incubator at 28°C until five days post fertilization,
when they were placed into individual tanks. When transferred to individual tanks, itgav guide 1,
itgav guide 2, and itgav guide 3 all had approximately thirty fish, and these were then raised to
three months of age. To genotype the fish, they were mated to wildtype fish and embryos were
taken from the pair matings and DNA was made using the MEEKER2 protocol.54 A PCR was
performed and then a restriction enzyme digest was performed on the PCR product. (Table 3 and
4). For the digest, each tube received 8.7 µl of water, 1 µl of 10X buffer (NEB), 0.3 µl of
enzyme, and 2.5 µl of PCR product. Each guide had a unique cut site that could be disrupted by
a mutation and different enzymes were used for each guide. (Table 5).
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Table 5. NEB Buffer/Enzyme Used for Each Specific Guide.
Guide Digested
Buffer Used
Restriction Enzyme Used
itgav Guide 1
itgav Guide 2

No cut site, heteroduplex
needed
Cutsmart

No cut site, heteroduplex
needed
Hpy1881

itgav Guide 3

2.1

BsaI

slc30a9 Guide 1

3.1

Hpy166II

slc30a9 Guide 2

2.1

Xcm1

slc3oa9 Guide 3

NA

NA

The digests were run on a 1.5% agarose gel, that had been stained using Gel Red to visualize.

Identification of Mutations in F1 and F2 progeny
Once identified on a digest gel, the DNA were was sequenced by Sanger Sequencing
Eurofins Genomics) (see below). Mutations were assessed using the 4 peaks program, serial
cloner 2, and NCBI Blast. Once the mutations were confirmed and analyzed, the remaining fish
were raised to three months of age. At three months of age, the fish were bred with a wildtype
fish to produce heterozygous F2 progeny. (Table 6). The remaining F2 progeny were raised to 8
weeks of age and some were euthanized for bone staining and sectioning. The remaining F2 fish
were kept for breeding future generations.
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Table 6. F1 Progeny of itgav and slc30a9 mutants.
F1 mutant
I2_G1.A_01F x WT
male
S2_G1.C_01F
S2_G1.A_01M
I2_G1.A_01M x
I2_G1.B_02F

Date of Birth

Number of progeny
alive at 8-weeks

Number of F2
mutants identified

4/4/17
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9

6/1/17
6/1/17
6/19/17

9
Not available
Not available

4
Not available
Not available

Whole Mount In situ Hybridization
To characterize gene expression of bambi, itgav, and slc30a9 whole mount in situ
hybridization was performed on 1 or 2 dpf wildtype embryos. The embryos were euthanized and
then stored in 100% MeOH in a -20°C freezer until use. This experiment is a three-day
procedure.

In situ Probe Generation
For the whole mount in situ hybridization, RNA sense and anti-sense probes were created
to test for specificity of gene expression. Probes were made with the Thisse et al. protocol.55 To
prepare the DNA template, 5 µg of wildtype zebrafish cDNA was linearized after a two hour
digestion with SpeI. The digest consisted of 43.5 ul of H2O, 5 µl of 10X Cutsmart Buffer
(NEB), and 1.5 µl of SpeI (NEB 10,000 U/ml). The resulting product was cleaned up with a
Bioline “Isolate” Kit. The product then was eluted at an estimated concentration of 0.25 µg/µl in
RNase-free H2O. Two microliters was then tested on a 1% agarose gel to check if the
linearization has been completed. The next step is the in vitro synthesis of the anti-sense RNA
probe via a transcription reaction. The 20 µl total reaction included 8 µl of nuclease-free water,
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4 µl of 5x transcription buffer (Promega), 2 µl of 10X DIG-NTP mix, 1 µl of T7 RNA
Polymerase (20 U/ µl), 1 µl of Rnasin (40 U/ µl), and 4 µl of linearized template DNA (5 µg).
The reaction was incubated at 37° C for two hours. 1 µl (2 U/ µl) of RNase-free DNase I was
added. The reaction was then incubated at 37° C for 15 minutes. The probe was then cleaned
up, after digestion was stopped by adding 1 µl of 0.5 M EDTA pH 8.0. After, 2.5 µl of 4 M LiCl
and 75 µl of 100% EtOH was added. The reaction was incubated at 80° C for 10 minutes. The
product was then centrifuged at 4° C for thirty minutes at 10,000Xg. The pellet was then washed
with 70% EtOH, then dried and suspended in 20 µl of DEPC H2O. Eighty microliters of Hyb+
(see below) was then added to the probe and stored in the -20°C until use.

Day 1 Protocol:
To begin, the embryos were rehydrated through a series of methanol/PBT washes described in
Table 7.

Table 7. Day 1 Washes for Whole Mount In-situ Hybridization.
Washes
Number of Washes
1
1
4

Solution Used (1mL):
66% MeOH/33%
PBT
33% MeOH/66%
PBT
100% PBT

Time
5 minutes
5 minutes
5 minutes

56

The embryos are then prehydridized in 500 µl of Hyb+ for one hour at 65° C. Then, the Hyb+
was aspirated off and a specific probe (500 ul) was added to the embryos. The samples were then
placed at 65° C overnight.
The solutions used:
•   PBT: 1x PBS and .01% Tween 20
•   Hyb+ solution (75 ml): Formamide (50 mls), 20x SSC (12.5 mls), 25 mg/ml Heparin,
(0.1 mls), 10 mg/ml tRNA, (2.5 mls), 20% tween-20 (0.25 mls), 1M citric acid (0.46
mls), nuclease-free H2O (9.19 mls)
•   Probe: dilute probe stock to 1:200 in 1x Hyb+, which was preheated at 65°C before use	
  

Day 2:
This day was a series of washes to prepare the embryos to receive the anti-digoxigenin antibody
for detection.
The first set of washes was done at 65° C and the second set of washes was done at room
temperature, described in Tables 8 and 9, on a rotator set at low speed.
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Table 8. Day 2 Washes for Whole Mount in-situ Hybridization at 65°C.
Washes in water bath at 65°C
Number of washes

Solution Used (500 ul)

Time

1

Hyb-

2 minutes

1

66% Hyb-/33% 2xSSC

10 minutes

1

33% Hyb-/66% 2xSSC

10 minutes

1

2x SSC

10 minutes

2

.2x SSC

20 minutes

Table 9. Day 2 Washes for Whole Mount in-situ Hybridization at room temperature
Washes on shaker at room temperature
Number of Washes

Solution Used

Time

1

66% .2x SSC/ 33% PBT

5 minutes

1

33% .2x SSC/ 33% PBT

5 minutes

1

PBT

5 minutes

The second stage of day two was an incubation period to prepare for the overnight
incubation with anti-digoxigenin antibody (Roche Diagnostics). After the last PBT wash was
completed, the solution was aspirated off. Block solution without the anti-digoxigenin antibody
(500 ul) was added and then incubated on a rotator at room temperature. Once the hour is up, the
block solution is aspirated and then replaced with the 1:10,000 anti-digoxigenin in block
solution. The embryos were incubated at 4° C overnight.
Solutions Used:
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•   Block Solution (1 ml): PBT (880 ul), BSA stock at 100 µg/ml (100 µl), and goat serum
(20 µl)
•   Block Solution w/ anti-digoxigenin antibody (1 ml): PBT (880 µl), 100 µl 100 µg/ml
BSA, goat serum (20 ul), and 1: 10,000 dilution of anti-Dig AP.
•   Hyb-: Formamide (25 mls), 20x SSC (12.5 ml)s, 20% tween-20 (0.25 mls), 1 M citric
acid (0.46 mls), H2O (11.79 mls)

Day 3:
Day three began with a series of washes, designed to clean any residue of the block +
anti-digoxigenin solution from the embryos, described in Table 18. Coloration buffer was then
added to prep the embryos for the final stage of adding NBT/BCIP to the coloration buffer to
induce coloration changes to show gene expression.

Table 10. Day 3 Washes for Whole Mount in-situ Hybridization.
Washes
Number of Washes

Solution Used

Time

1

PBT

2 minutes

5

PBT

15 minutes on shaker

3

Coloration Buffer

5 minutes on shaker

1

Coloration Buffer with
NBT/BCIP

Speed of color development is highly
varied, depends on how strong probe is

Once the coloration reaction completed, the reaction needed to be aspirated and rehydrated
through a series of methanol/PBT washes, described in Table 11.
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Table 11. Day 3 of Whole Mount in-situ Hybridization for Rehydration Washes.
Rehydration Washes
Number of Washes

Solutions Used

Time

1

100% MeOH

5 minutes

1

66% MeOH/33% PBT

5 minutes

1

33% MeOH/ 66% PBT

5 minutes

4

PBT

5 minutes

Embryos were then equilibrated in 1xPBT + 50% glycerol and imaging was undertaken with an
Olympus SXZ12 microscope.

Solutions Used:
•   Coloration Buffer: 1 M Tris-HCL pH 9.5 (5 mls), 1M MgCl2 (2.5 mls), 5 M NaCl (1 ml),
and H2O (41.5 mls)
•   Coloration Buffer with NBT/BCIP: 1 M Tris-HCL pH 9.5 (5 mls), 1 M MgCl2 (2.5 mls),
5 M NaCl (1 ml), H2O (41.5 mls), NBT (4.5 µl), and BCIP (3.5 µl)

Colorimetric in situ Hybridization on Paraffin Sections
To detect gene expression of the three candidate genes on adult fish, paraffin sections
were performed. To make 4% paraformaldehyde (PFA) two grams of PFA were added to 50 mls
of PBS. The solution was then heated at 65° C overnight to dissolve the solids. Fish were
euthanized with 0.4% Triciane at 8 weeks of age and then the heads were cut off at the posterior
end of the gills. Heads were then fixed in 4% PFA for a week on a shaker at 4°C.
Decalcification was then performed to prep for embedding.56 For the decalcification protocol,
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20% EDTA was prepared. DEPC water (47.5 mls), 10M NaOH (2.5 mls), and 10 grams EDTA
was added to a 50 ml tube and shaken until properly dissolved. Heads fixed in 4% PFA were
transferred to the 20% EDTA and placed on the shaker at 4°C for a week, until completely
decalcified. After a week, the heads were rinsed in DEPC water twice for 10 minutes,
DEPC/30% EtOH for 10 minutes, DEPC/50% EtOH for 10 minutes, and DEPC/70% EtOH for
10 minutes. Fish heads were stored in DEPC/70% EtOH and sectioned at the Massey Cancer
Center’s Cancer Mouse Models Developing Shared Resource by Pamela J Gigliotti. Paraffin
sections were of a 120 µm thickness and six sections were taken for mounting. Once sectioned,
the sections were stored at -80°C until use.
Day 1:
Slides were baked at 60°C for 1 hour prior to the start of the experiment. Every piece of
equipment used was wiped before use with RNase-Away (Molecular BioProducts) to insure
there was no contamination with RNase. A small coplin jar with a capacity of holding four slides
and 50 ml of solution was used in the experiments. The first part of day was the deparaffinization
stage, which consists of a series of washes and is performed in a fume hood, described in Table
12. This step removed the paraffin covering the slide.
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Table 12. Day 1 Deparaffinization Washes for Colormetric in-situ Hybridization for
Paraffin Sections.
Deparaffinization
Solution Used (50 mL):

Time

Xylene Substitute

5 minutes in jar

Xylene Substitute

10 minutes in jar

100% Ethanol

5 minutes in jar

80% Ethanol

10 minutes in jar

PBST (1x PBS with 0.1% Tween 20)

5 minutes in jar

The second part of day one was permeabilization, the stage in which the tissue is made
penetrable, allowing the mRNA to become accessible to the probe of choice. See Table 13. This
was then succeeded by a fixation step to insure the tissue stays intact.

Table 13. Day 1 Permeabilization Washes for Colormetric in-situ Hybridization for
Paraffin Sections.
Permeabilization
Solution Used

Time

10 mg/ml Proteinase K (20 µl)

5 minutes on slide

PBST (50 ml)

5 minute in jar

8% PFA with 0.2% Glutaraldehyde (5 µl)

20 minutes on slide

PBST (50 ml)

5 minutes in jar

The final stage of day one was hybridization, in which mRNA’s secondary structure becomes
denatured to allow the probe to bind. The slides were placed in a humidified chamber with 200
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µl of Hyb-Buffer at 68° C for one hour. After an hour, a specific probe was placed on the slide in
the humidified chamber. The chamber was then placed at 68° C overnight.

Solutions are made of:
•   PBST: 50 mls of PBS, 500 µl of Tween 20
•   Proteinase K: 10 mg/ml in DEPC water
•   8% Paraformaldehyde (10 ml): 5 mls 4% PFA, 80 µl of 25% Glutaraldehyde, 1 ml of 10x
PBS, and 3.92 mls of DEPC water

Day 2:
The first stage of day two was a series of washes that were designed to remove any
unspecific RNA to reduce background staining. Wash solutions were preheated to 68° C. The
second stage of day two was antibody incubation to prepare the probe for antibody dilution.
Table 14. Washes to reduce background staining.
Washes
Number of Washes
1

Solution Used
Wash Buffer (50 ml)

Time
15 minutes

2
3

Wash Buffer (50ml)
MABT (50 ml)

30 minutes
15 minutes

To prep for antibody incubation the slides were then covered with 2% Roche Blocking Agent
and left at room temperature for one hour. The blocking agent was removed around the slide,
until no standing liquid is observed. Afterwards, the slides were covered in the antibody
dilution, placed in the humidified chamber and incubated overnight at 4°C. The humidified
chamber consisted of a medium size Tupperware container, which had inside a wet paper towel
63

and a block on which the slides were placed. This chamber was used to prevent probes from
drying out or tissues coming off with a cover slip.

Solution Used:
•   Wash Buffer: 25 mls of Formamide, 23 mls of DEPC water, 2.5 mls of 20xSSC, and 50
µl of Tween 20
•   MABT: 40 mls of DEPC water, 10 mls of 5x MAB, and 50 µl of Tween 20
•   5xMAB: 500 mM Maleic acid, 150 mM NaCl, adjust to pH 7.5 with NaOH
•   2% Roche Blocking Agent: 1 ml of MABT and .02 grams of Roche Blocking Agent
(heated at 60°C until blocking reagent is dissolved)
•   Antibody Dilution: 1 ml of MABT, .02 grams of Roche Blocking Agent, and 0.05 µl of
anti-DIG antibody (1:2,000)

Day 3:
The final day of the experiment was the color reaction and staining, in which coloration
buffer was added to produce visible staining on the slide. (Table 15). Images were taken on an
Olympus SZX12 microscope.
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Table 15. Washes to Prep for the Staining Solution.
Washes
Number of Washes

Solutions Used

Time

3

MABT

15 minutes in jar

2

Coloration Buffer

5 minutes in jar

1

Staining solution

until staining is clearly visible

3

PBST

5 minutes in jar

Solution Used:
•   Coloration Buffer (50 mls): 5 mls 1M Tris pH 9.5, 2.5 mls 1M MgCl2, 1 ml 5M NaCl, 50
µl of 100% Tween 20, 50 µl of 2M Tetramisol, 41.4 mls of DEPC water
•   Staining solution: 1 ml of Coloration Buffer, 5 µl of BCIP, 3.5 µl of NBT

Hematoxylin and Eosin Staining (H&E staining)
One of the most frequently used staining methods is hematoxylin and eosin staining. The
staining system is composed of two different dyes, Eosin and Hemotoxylin. Eosin is an acidic
dye that is negatively charged and stains basic structures of tissues pink. Tissues that are
typically pink are mostly proteins, which includes cytoplasmic filaments in muscle cells. By
contrast, hematoxylin is a basic dye that is positively charge and stains acidic tissue structures
blue. Tissues that are typically stained blue are DNA, RNA, and carbohydrates in cartilage.
Fish were euthanized at 8 weeks of age and put in a 50-ml tube of 4% paraformaldehyde
in PBS. The tube was then placed on a shaker at 4° C for a week. After a week, the fish heads
were put through the same decalcification protocol as for paraffin sections.56 Once decalcified,
fish heads were stored in DEPC/70% EtOH and then sent away to Pamela Gigliotti in the Massey
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Cancer Center’s Cancer Mouse Models Developing Shared Resourcet for H & E staining
preparation. Sections were of a 120 µm thickness and six sections were taken for mounting.

Bone and Cartilage Staining:
All bone and cartilage staining was done at 9 weeks of age. All staining was performed
using the Blue protocol.57 Fish were euthanized once they reached the required age and then
fixed in 2% paraformaldehyde in PBS for 3 hours on a rotator, at room temperature. The fish
were then washed in 100 mM Tris/1 M MgCl2 for 30 minutes on a rotator. The next step was to
place the fish in .02% Alcian Blue/10 mM MgCl2, pH 7.5 on a shaker at room temperature
overnight. The next day the fish go through a series of ethanol washes. They first were washed
in 80% EtOH/100 mM Tris, pH 7.5/10 mM MgCl2 for thirty minutes on a rotator. They were
then washed in 50% EtOH/100 mM Tris, pH 7.5/10 M MgCl2 for thirty minutes on a shaker.
The final part of the ethanol washes was done with 25% EtOH/100 mM Tris, pH 7.5/10 mM
MgCl2 for thirty minutes. Fish were then placed in a 50 ml tube containing 0.5% KOH solution,
which consists of 5 mls 100% Glycerol, 1.25 mls 20% KOH, and 42.75 mls of water and placed
on the shaker for thirty minutes. A 50-ml solution of 3% H2O2/0.1% KOH was then made, and
fish were placed in the solution, to remove excess pigment, to allow for better visibility. A rinse
was then performed to stop the bleaching process with a solution of 35% 1 M NaBo4 and the
tube was placed on a shaker for thirty minutes. Another rinse, designed to clear/digest the fish’s
organs was then undergone with 1% Trypsin in 35% Saturated NaBO4 on a shaker at low speed,
for thirty minutes. A wash in 10% glycerol/.0.5% KOH was then performed for thirty minutes
on a shaker. The bone staining in 0.01% Alizarin Red, pH 7.5, was performed on a shaker
overnight. After the overnight staining, a wash in 50% glycerol/0.1% KOH was performed for
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thirty minutes on the shaker. The final wash was performed overnight without agitation, again in
50% glycerol/0.1% KOH at room temperature. Imaging was undergone with a Olympus SZX12
microscope and the storage of stained skulls and spines was placed in 70% glycerol in water at
room temperature. Magnification varied, however all spines were shot at 11.2x magnification,
while skulls were shot at 32x magnification.

Sanger Sequencing
All F1 fish were genotyped using the previously mentioned primers in Table 4. If a
mutation was suggested by digest results, the sample was sent off for sequencing after sample
preparation to Eurofins Genomics. The PCR products were cleaned using Bioline Isolte II PCR
clean up kit. The volume of the sample was brought up to 50 µl with H2O. The PCR product
was put in a gel column inside a 2-ml collection tube and centrifuged at 11,000 x g for thirty
seconds. Seven hundred microliters of Wash Buffer CW was added to the gel column, which
was then centrifuged at 11,000 Xg. The silica membrane was then dried after being centrifuged
for 1 minute at 11,000 Xg to remove residual ethanol, and the gel column was placed in a new
tube. Fifteen microliters of Elution Buffer C was then added to the silica membrane, incubated
for 1 minute, and then centrifuged for a minute at 11,000 x g. Once the results were received
they were visualized with the program 4Peaks to read the sequence. The sequence was then
analyzed by NCBI blast where it was aligned with either the itgav or slc30a9 reference sequence.
Once the sequences were aligned, any differences were checked in the program Serial Cloner2.
The original sequence was copied into the program and then we manually changed the sequence
to that were found in the mutant fish. We then aligned the wildtype and mutant sequence,

67

highlighted any differences between the two, and assessed the level of severity that the mutations
caused in the genes.

Suture Measurement
Zoomed in pictures of the sutures were taken by a Zeiss: Axiocam 503 color microscope
using the ZFIN program at 32x magnification. Images were saved as jpegs and then opened in
the program Image J. There were six different measurements taken. The sagittal suture length,
the left and right coronal suture length, the length of the interfrontal suture, the width of the
interfrontal bones, and the length of the interfrontal bone were all measured. The software used
to calculate the statistic was PRISM 2.0. Two-tailed ANOVAS and unpaired t-tests were used,
and will be discussed in greater depth which test was performed for which in the results section.
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Chapter 3: Results

Genotyping for the BMP2 SNP, rs1884302 and BBS9 SNP, rs10262453
We genotyped three families for the BMP2 risk allele CS 64 (members CS 64-66), CS 14
(members CS 14 and 15), and CS 4 (members CS2-7). Two families (CS 2-7 and CS 14-15)
were previously identified with NSC and had possible candidate genes identified, yet the
candidate genes did not segregate with the synostosis phenotype. These two families were
chosen in order to determine if the risk alleles allowed us to explain CS observed in the families.
We amplified the region flanking the BMP2 SNP and digested the PCR product with the EcoRI
enzyme. Two bands, one at 128 bp and one at 92 bp, are indicative of having the C risk allele
while one band at 220 bp indicates the T allele, which has not been shown to be associated with
CS. The results show for CS 64 family individuals, CS 64 and CS 65 are heterozygous for the C
allele which confers risk, while CS 66 does not. (Figure 11). CS 2-7 results show that the entire
family carries the C risk allele (Figure 12). The results for CS 14-15 show that neither carry the
C allele and instead are homozygous for the T allele. (Figure 13).
The BBS9 SNP was genotyped by heteroduplex analysis on individuals CS 2-7 and CS
14-15. Two bands around the 164-base pair region indicate there is a C and an A allele present
in the SNP. This is due to sequence differences in the heteroduplex fragments, so the fragments
do not run true to size. The results in Figure 14, show that CS 2-7 and CS 14-15 all have an A
and a C allele at the BBS9 SNP. The C allele has been associated with increased risk of CS.
These CS samples were run with two control samples that had been sequenced and found to have
an A and a C at the SNP location. If the individual is a homozygous C or A at the SNP, a single
band is seen at 162
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220 bp, T allele
128 bp, C allele
92 bp, C allele

Figure 11. Genotyping Gel for BMP2 for CS 64 family. PCR and digest results from
genotyping the BMP2 risk allele for patients CS 64-66. Gels were run on a 2% agarose gel for
45 minutes at 100V. Results show that both CS 64 and CS 65 have the risk allele, while CS 66
does not. Relevant bands are located at 128 and 92 for the risk alleles, and 220 for a non-carrier.
There are many nonspecific bands observed in the samples.
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100 Base pair
ladder

CS 2
Digest

CS 3
Digest

CS 4
Digest

CS 5
Digest

CS 6
Digest

CS 7
Digest

128 bp, C allele
92 bp, C allele

Figure 12. Genotyping Gel of BMP2 for CS 2-7 family. Results for CS patients 2-7. Gel was
run on a 2% agarose gel with a 100 base pair ladder. The results show that CS 2-7 all have the
risk allele.

71

100 base pair ladder

220 bp, T allele
Control
PCR

Control
Digest

CS 14
PCR

CS 14 CS 15 CS 15
Digest PCR Digest

Figure 13. Genotyping Gel of BMP2 for CS 14-15 twins. Results from a PCR and digest gel,
genotyping for the BMP2 risk allele from patients, CS 14 and CS 15. The gel was run on a 2%
gel with 100 base pair ladder at 100 V for 45 minutes. Results show that CS 14 and CS 15 don’t
carry the BMP2 risk allele.
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Control Control

CS 15

CS 14

CS 7

CS 6

CS 5

CS 4

CS 3

CS 2

Figure 14. Heteroduplex analysis of BBS9 SNP. This was run on an acrylamide gel with a 100
base pair ladder. Two bands around the two hundred base pair ladder indicate that all samples of
CS 2-7 and CS 14-15 all have an A and a C at the BBS9 SNP. White arrows indicate an example
of a heterozygous BBS9 individual looks like, two bands indicate there is a A and a C allele
present in the sample. The ladder is a 100 bp ladder.
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Whole Mount in situ Hybridizations for itgav, bambia, and slc30a9
To evaluate these genes as candidates for CS, one needs to analyze whether they are
expressed in the relevant stage and tissues. To do this, in situ hybridization on paraffin sections
of 8-week-old, wildtype zebrafish was performed. To verify that the riboprobes were specifc, we
performed whole mount in situ hybridization on embryos to check that the riboprobes were
capable of detecting their mRNAs and there was no cross hybridization with the sense probe.
The results for itgav anti-sense riboprobe show that itgav is expressed in the head of the
zebrafish at 1 dpf. (Figure 15). The results for the sense riboprobe show no staining so the results
observed with the anti-sense riboprobe are specific and not due to nonspecific binding. (Figure
15). The bambia anti-sense riboprobe showed that at one day post-fertilization it is expressed in
the retina, dorsal epidermis, and the proctodeum. (Figure 16). The bambia sense riboprobe did
not show any nonspecific binding. (Figure 16). The results of the anti-sense slc30a9 riboprobe
showed gene expression in the head at two-day post fertilization of a wildtype embryo, however
when tested at one day post fertilization, no expression was observed. Results of the anti-sense
slc30a9 riboprobe were confirmed using a sense slc30a9 riboprobe to act as a control for
background expression. (Figure 17).
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A)

B)

Figure 15. itgav Wholemount in situ Hybridization. A) Picture is of a 1 dpf wildtype embryo
that has been incubated with an itgav anti-sense probe. Expression is seen in the head of the
embryo. B) A 1 dpf wildtype embryo that was incubated with a sense probe to act as a negative
control to control for background expression.
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A)

B)
Dorsal epidermis

Retina

Proctodeum

Figure 16. bambia Whole Mount in-situ hybridization. A) A 1 dpf wildtype zebrafish embryo
that was incubated with a bambia anti-sense riboprobe. Expression is observed in the retina,
dorsal epidermis, and proctodeum of the zebrafish. B) A one day post fertilization wildtype
zebrafish embryo that was incubated with a bambia sense riboprobe and not expression is
observed.
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A)

B)

C)

D)

Figure 17. slc30a9 Whole Mount in-situ hybridization. A) A 2 dpf wildtype embryo that was
incubated with a slc30a9 anti-sense riboprobe. Expression was based heavily in the head. B) A 2
dpf wildtype embryo that was incubated with a slc30a9 sense riboprobe to serve as a control
against background coloration. Bottom left: A 1 dpf wildtype embryo that was incubated with a
slc30a9 anti-sense riboprobe. No expression was seen at this time. Bottom right: A 1 dpf
wildtype embryo that was incubated with a slc30a9 sense riboprobe. No expression was seen at
this time.
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in situ Hybridization on Paraffin Head Sections
As it is not known if itgav, bambia, and slc30a9 are expressed in the adult skull, in situ
hybridization were performed on wildtype, 8-week-old zebrafish. At 8 weeks of age, itgav is not
expressed in the zebrafish skull. (Figure 18). bambia was found to be expressed in the 8-week
wildtype zebrafish head. The bambia anti-sense probe showed that bambia expression is heavily
concentrated in the jaw, eyes, and in the cranial skull, including the sagittal suture (Figure 19).
The bambia sense probe served as a control against background expression, and showed no
background coloration (Figure 19). The results of testing the anti-sense slc30a9 riboprobe show
that slc30a9 is expressed in a wildtype, 8-week-old zebrafish. It was found primarily to be
expressed in the jaw as well as in the skull and cranial suture (Figure 20).

78

A)

Brian

Jaw

B)

Figure 18. Colorimetric in situ hybridizations of itgav. Paraffin section on 8
week, wildtype zebrafish. Section is orientated in a cross-section. A) An example
of the itgav anti-sense probe. B) An example of the itgav sense probe.
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A)

Brain

Eye

Jaw

B)

Sagittal Suture

C)

Figure 19. Colormetric in situ hybridization of bambia. Sections are in a caudal view of the
head. A) in-situ hybridization of a paraffin head section of an 8-week-old, wildtype zebrafish,
anti-sense bambia probe. B) in-situ hybridization of a paraffin head section of an 8-week-old,
wildtype zebrafish, sense bambia probe. C) Close up of the sagittal suture of an 8-week-old,
wildtype zebrafish, anti-sense bambia probe. Results show bambia is expressed at this time
period. 144x magnification.
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Jaw

Sagittal Suture
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Figure 20. Colormetric in situ hybridization of slc30a9. Sections are in a cross-section. A) An
in-situ hybridization on an 8-week-old, wildtype zebrafish paraffin head section (40x) using a
slc30a9 anti-sense riboprobe. B) An in-situ hybridization on a 8 week old, wildtype zebrafish
paraffin head section (40x) using a slc30a9 sense riboprobe. C) Sagittal suture of an 8-week-old,
wildtype zebrafish, 144x.
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Overexpression of bambia Results
The F0 overexpression transgenic line of bambia were grown up to 3 months of age. Out
of the 40 embryos injected with the transgene only 8 survived to adulthood. Of the 8 that
survived, only 7 were able to be successfully bred to wildtype fish. The overexpression bambia
transgene had a fluorescent protein, in which we were able to scan embryos three days post
fertilization to see if there was germline transmission. Embryos from each line were scanned and
no germline transmission was seen. As no germline transmission was present in any of the F1
progeny, no phenotypic analysis could be done.

Formation of Genetically Modified Zebrafish Lines
To overexpress bambia, a transgene was inserted in a heat shock promoter vector. To
knockdown itgav and slc30a9, CRISPR/Cas9 was used. ITGAV and SLC30A9 each had three
different CRISPR/Cas9 guides. Forty wildtype embryos were injected for each guide, with
various rates of survival (Table 16). At around three months of age, there were around 15 fish
left in ITGAV guide 1. These fish were unable to be mated, due to their sickly appearance and
small size. ITGAV guide 2 and ITGAV guide 3 at three months of age, had around 24 fish that
survived. The fish appeared normal in size and could breed and produce viable offspring.
SLC030A9 guide 1 had 8 fish that survived to three months of age. SLC30A9 guide 2 had around
22 fish and could reproduce viable offspring. SLC30A9 guide 3 had around 7 fish at three
months of age, with a three of them having distinct abnormal eye coloration and another three
have failed to thrive. To check if CRISPR/Cas9 knockdowns were successful, F0 fish were
mated and eight embryos of each guide were taken after 1 dpf and a heteroduplex/and or a
restriction digest was performed to check if mutations had occurred.
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Table 16. F0 Fish Information.
ITGAV
ITGAV
Guide 1
Guide 2
Injected
40
40
Number left 29
28
at 4 weeks
Number left 15
24
at 12 weeks
Number of
not
3/12
F0 fish with screened
germline
transmission/
F0 fish
screened

ITGAV
Guide 3
40
20

SLC30A9
Guide 1
40
14

SLC30A9
Guide 2
40
25

SLC30A9
Guide 3
40
9

24

8

22

9

3/8

1/4

3/9

not
screened

Embryos of F0 fish that tested positive for germline transmission (F1 progeny) were then raised
up until six weeks of age, and then genotyped with a PCR and a restriction digest to check for
mutations. Samples showing mutations were then shipped off to be sequenced to assess what
type of mutation had been induced. All sequencing was done through Eurofins Genomics.

Creation of itgav and slc30a9 Mutants Lines
While fish from all six guides survived until three months, some fish injected with
specific guides were not as healthy as the others, and as such were unable to reproduce. Slc30a9
guide 1 and slc30a9 guide 2 each had 26 fish and slc30a9 guide 3 only had 15 fish survive.
Control fish for itgav numbered around 35 fish, and unfortunately an accident in tank setup led to
the control slc30a9 fish dying. Fish were grown until they reached three months of age, and then
breeding began. Fish were crossed with wildtype fish to check if germline transmission of
mutations had occurred (Table 16). Unfortunately, itgav guide 1 and slc30a9 guide 3were unable
to bred. Fish in these lines failed to thrive and when set up to mate, failed to reproduce after
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multiple attempts. However, numerous F0 fish from other guides were successfully found to
have germline transmission, as shown in Table 16. The progeny of the F0 (F1s) were allowed to
grow until six weeks of age, and then the fish were genotyped. Several F1 fish heterozygous for
mutations in itgav and slc30a9 were identified and the most deleterious were selected for
breeding and further genetic analysis. (Table 17). The itgav F1 mutants grew at a similar rate to
their wildtype siblings, however with the slc30a9 F1 mutants, their growth appeared stunted,
however it is not yet known if due to the mutation or a tank density issue. Both F1 lines of itgav
and slc30a9 were able to be successfully bred to wildtype fish in order to produce F2
heterozygous progeny. (Table 18). While there should have been able equal numbers of F2
itgav mutants, due to the severity of the itgav phenotype, it is predicted that some died during the
development into adulthood. The mutant chosen to study for itgav was I2_G1.A_01F, due to its
deletion that produces a frameshift that leads to a premature stop codon. (Figure 21). Two F1s
mutants of slc30a9 were bred to create F2 progeny.
One of the mutants S2_G1.A_0M, contains a three base pair deletion that removes a serine. The
other mutant, S2_G1.C_01F had a two base pair deletion, that creates a frameshift leading to a
premature stop codon (Figure 22).
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Table 17. F1 lines produced by F0 germline transmission carriers.
F0 Parent
Number of progeny
Number of F1 mutants
alive at 6 weeks
identified (Fish ID
number)
I2_G0.A_01F x WT
9
1 (I2_G1.A_01F)
male
I2_G0.B_02F x WT
3
1 (I2_G1.B_01M)
male
I2_G0.B_02F x
3
1 (I2_G1.B_02F)
B1212 male
S2_G0.A_01F x WT
45
1 (S2_G1.A_0M)
male
S2_G0.A_01F x
50
1
B1212 male
S2_G0.C_01M x WT
3
1 (S2_G1.C_01F)
female
I3_G0.A_01F x WT
22
6
male
I3_G0.A_01F x
8
2
I3_G0.B_01M
I3_G0.A_01F x
30
2 (I3S2_G1.A/.B_01F)
S2_G0.B_01M
(I3S2_G1.A/.B_01M)
S2_G0.A_01F x
10
3
S2_G0.B_01M
Table 18: F2 lines produced by F1 carriers.
F1 Parent
Mutation(s) found
I2_G1.A_01F
S2_G1.A_0M
S2_G1.C_01F

25 bp deletion
leading to a
premature stop
Three base pair
deletion
two base pair
deletion, leading to
premature stop

Number of F2 mutant
progeny
9

Number of F1
non-mutants
identified
8
2
2
27
6
2
16
6
28
7

Number of F2 nonmutant progeny
found
35

NA

NA

4

5
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Figure 21. Comparison of a wildtype and an itgav mutant sequence. The top picture
represents a wildtype sequence. Sequence represents the itgav sequence in one allele of the
I2_G1.A fish. Pictured are the amino acids that are deleted in the itgav mutant, while *
indicates a stop codon.

86

Figure 22. Visualization of the comparison between a wildtype slc30a9 fish and the two
mutant slc30a9 fish. For S2_G1.A_0M, a three base pair deletion caused there to be a
deletion of a serine in the sequence. For S2_G1.C_01F, a two base pair deletion caused there
to be a frameshift mutation, which lead to a premature stop codon.

Bone and Cartilage Staining
Bone staining was performed on wildtype F2s, heterozygous itgav G2 F2s and
heterozygous itgav F1s (however exact itgav mutations are not known for this line). Bone
staining was performed at 9 weeks post fertilization. Cartilage is stained blue, while bone is
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stained red. Cartilage stains blue due its secretion of glycosaminoglycans, which the Alcian blue
binds too.58 The Alizarin red stain binds to the calcium present in bones.58 In the zebrafish lines,
we are assessing the skull to check if there are any noticeable differences in suture closure
between our mutated and wildtype lines. In wildtype zebrafish, the sutures never fully close,
which is the main difference between humans and zebrafish. Results of bone staining of 6-weekold wildtype zebrafish show that the sutures are easily identifiable and are not fused (Figure 23).
For the heterozygous itgav mutants, one line of F2 fish from itgav guide 2 (I2_G2), was created
that had a 25 bp deletion, resulting in a frameshift mutation which created a premature stop
codon at base pair 1027 (Figure 21). Four mutant fish were selected and bone stained at 9-weeks
of age. For comparison, 4 wildtype siblings of the F2s (I2_G2_WT) were used as controls. In
addition, 4 F1 fish of itgav G3 (I3_G1) were genotyped and found to be mutants and bone
stained at 11 weeks. It is important to note, while the F2 mutants should have the same itgav
mutation of the sequenced founder I2_G1.A_01F, the other F1 mutants do not have the same
itgav mutation and the exact mutation in each fish is not known, due to poor sequencing read
outs. The F1 itgav mutants were only bone stained due to access to spare F1 mutants, and it was
not thought at the time that any phenotype would be seen. The different lines were assessed
according to head shape, spine curvature, and skull shape.
When reviewing the skulls, it is apparent that there is a shortening of the skull observed
in the I2_G2 and I3_G1 mutants. The head shape in both the I2_G2 and I3_G1 mutants appear to
be compressed, leading to a squashed appearance of the face and jaw, when compared to the
wildtype. (Figure 24). Different levels of severity in the skull phenotype are seen in the two
lines of itgav mutants, indicating that different mutations in itgav produce variable phenotypes.
However as the exact itgav mutations of the I3_G1 mutants are not known, it is can’t be
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concluded which fish in that line had what itgav mutation and what that itgav mutation produced
as a phenotype. Of interest to note is also the curvature of the spine that is seen in both the
I2_G2 and I3_G1 mutants. The spines of zebrafish are normally straight, while the spines of the
mutants are curved to various degrees, with the I2_G2 mutants having the same curve and I3_G1
mutants having various spinal curvatures. (Figure 25). Again, different levels of severity are seen
in the F2 and F1 itgav mutants, showing variable spinal curvature phenotypes in different itgav
mutations. The frontal bones of the skull appear to be shorter and the parietals of the mutants
appear asymmetrical, leading to a shortened and compressed skull with abnormalities. (Figure 26
and 27). Due to the noticeable differences seen in the skulls of I2_G2 WTs and I2_G2 mutants,
measures of several key areas of the skull were undertaken. Length of the sagittal suture, the
length and width of the interfrontal suture, coronal to interfrontal suture length, left and right
coronal suture measurements were assessed. No statistically significantly difference was seen in
sagittal suture length, bicoronal suture, and length of the anterior frontal bone. (Figure 28).
When the I2_G2 WTs and the I2_G2 mutants were compared, statistically significant differences
were seen in the length of the right coronal suture, the width of the interfrontal bones, and the
length of the interfrontal suture. (Figure 29, 30, and 31). The right coronal suture was significant
smaller in the itgav mutants compared the wildtypes and the left coronal suture. The interfrontal
bones were wider in the itgav mutants, compared to wildtype. The interfrontal suture in the itgav
mutants was also shorten when compared to wildtype. This explains the asymmetrical, shorten
skull shape seen in the itgav mutants. Results in figures 29 and 30 had a two-way ANOVA with
Bonferroni corrections performed, while results from Figure 31 were obtained through an
unpaired t-test.
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Interfrontal Suture
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C)

Coronal Suture
Sagittal Suture

Figure 23. The sutures of a wildtype zebrafish. A) The sutures of a six-week-old,
wildtype zebrafish skull at 40x magnification. B) Interfrontal suture at 51x
magnification. C) Coronal and Sagittal suture at 51x magnification.
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D)

H)

B)

E)

I)

C)

F)

J)

G)

K)

A)

Figure 24. A sagittal view of the zebrafish skulls. A-C) Skulls of the F2 progeny of
I2_G1.A_01F that were wildtype. Compared to the F2 mutants, these skulls had no
malformations. D-G) Skulls of the F2 progeny of I2_G1.A_01F, each with the same
mutation. Skulls of these face are shorten, asymmetrical, and compressed. H-K)
Skulls of the F1 itgav mutants. The exact itgav mutations of the F1 mutants are not
known. Images taken at a 25.6x magnification.
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Figure 25. Results of the Bone and Cartilage Staining: Spines. A-D) Represents I2_G2
wildtype progeny. Here the spine is straight with little to no curve E-H) Represents I2_G2
mutants. The spine is clearly curved compared to their wildtype siblings. I-L) Represents the
I3_G1 mutants. The exact mutation for each fish is not known, however all have variable
levels of severity in the spine curvature. Images taken at a 11.2x magnification.
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A)

B)

C)

Figures 26. Results of the Bone and Cartilage Staining: Skulls. A) The top row
shows I2_G2 mutants. B) The middle row shows I2_G2 wildtypes. C) The bottom
row shows I3_G1 mutants. The figure shows the compression of the itgav mutant
skulls as well as the asymmetrical, shorten skull. Images taken at 25.6x
magnification.
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Right

Left

Wildtypes

itgav
Mutants

Figure 27. Comparison of the F2 progeny of I2_G1.A_01F. Top row: Depicts I2_G2_
wildtype skulls at 9 weeks of age. Bottom row: Depicts I2_G2 mutants at 9 weeks of age.
Images taken at 32x magnification. The figure emphasizes the shorten length of the mutant
skulls as well as the asymmetrical right side of the skull when compared to the left. In
addition there is a broad interfrontal bone on the mutants when compared to the wildtypes.

95

A)   	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   (mm)

C)	
  

B)  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  D)	
  
Length of frontal bone (mm)

(mm)

Figure 28. Visualization of the measurements that are not statistically
significant. A) Pictured are the wildtype F2s and the itgav F2 mutants
measurements, 1 = B) length of interfrontal bone, 2 = C) length of left coronal
suture, and 3) length of sagittal suture. B) Bar graph that shows the comparison
between the wildtype and itgav mutants anterior frontal bone length, no significant
difference is seen. C) Bar graph that shows the comparison between wildtype and
itgav mutants of length of the left coronal suture. No significant difference is seen.
D) Bar graph that shows the comparison between wildtype and itgav mutants of
the sagittal suture length.
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Wildtype

itgav
Mutants

Figure 29. Comparisons of the length of the right coronal suture (mm) between wildtype
I2_G2’s, mutant I2_G2’s, and mutant I3_G1’s. A) Comparison of the both coronal sutures
between 9-week-old wildtypes and itgav mutant. B) A statistical signification was seen between the
wildtype and mutant I2_G2’s which suggest that the mutant in itgav is causing a smaller right coronal
suture, indicating asymmetry of the skull (p-value = 0.0445).
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A)

B)
(mm)

Wildtypes

itgav
Mutants

Figure 30. Comparison of the width of the interfrontal bone (mm) between wildtype
I2_G2’s, mutant I2_G2’s, and mutant I3_G1’s. A) Visual representation of the
differences seen in the width of the interfrontal bones between 9-week-old wildtype fish and
itgav mutants. B) A significant difference (p-value = 0.0225) was seen between the wildtype
I2_G2’s and the mutant I2_G2’s. This suggests that the itgav mutation produces wider
interfrontal bones.

A)

B)
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Length of the Interfrontal Suture

Wildtypes

itgav
Mutants
Figure 31. Comparison of a portion of the sagittal suture, located between coronal
and interfrontal suture, between wildtype I2_G2’s and mutant I2_G2’s. A) Visual
representation of the differences observed in the length of the interfrontal suture
between 9-week-old wildtypes and itgav mutants. B) A significant difference (p-value
= 0.0109) was shown, suggesting that the itgav mutation causes a shorten sagittal
suture, which could be why the mutant skulls appear compressed when compared to
the wildtypes.
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Hematoxylin and Eosin Staining
H & E staining was performed to produce a phenotypic analysis of the sutures of a
zebrafish skull. Structures that are stained pink (Eosin) are considered basic in nature, and most
muscle in the fish head are pink. Structures that are stained a purple blueish (Hematoxylin) are
considered acidic in nature, and prime examples of this is the eye and gills of the fish head. In
wildtype fish heads at 8 weeks of age, we can see there is no fusion of the sutures. (Figure 32). In
addition, two I2_G2_WTs, two I2_G2 mutants, and two I3_G1 mutants were sent off to receive
H&E staining to check for any noticeable differences in suture closures at 9 weeks of age.
Results of the head sections of the itgav mutants and wildtypes revealed stark differences in
several key areas of the head. When examined in caudal view from the back of the skull, key
differences were observed. The itgav F2 mutants had asymmetrical skull shapes, in which the
right side of the skull is sloped in, while the left is raised. Portions of the right side of the brain
appear to be compressed, and additional portions appear to be missing. In addition upon
examination of the sagittal suture, the suture of the itgav F2s had additional layers of bone when
compared to the wildtype F2s. (Figure 33). When analyzing the caudal view of the interfrontal
suture of the wildtype F2s to the itgav mutant F2, it was found that additional layers of bone
were present in the mutants at the interfrontal suture. (Figure 34). Whole head sections of a
sagittal view were next analyzed and the lambdoid, coronal, and interfrontal were checked. The
lambdoid suture when compared, appears to be missing from the itgav mutants. (Figure 35). The
coronal suture in the wildtype fish are open and appear unfussed, however with the itgav mutants
there is additional bone formation as well as the suture appearing to be nearly closed. (Figure
36). The interfrontal suture in wildtype fish are clearly open, however in the itgav mutants,
increased bone formation as well as abnormal suture development. (Figure 37). In addition to

100

the bone abnormalities seen in the itgav mutants, there were other differences observed. The
heart of the itgav F2 mutants when compared to wildtype F2s were abnormally shaped and
structured and had less muscle tone. (Figure 38).
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Figure 32. Sagittal view of a 8-week old zebrafish head. A) Lateral sagittal cut, head of an 8week-old wildtype zebrafish, blue box indicates the coronal suture and black box indicates the
sagittal suture. 32x B) Coronal suture of a 8-week old wildtype zebrafish, sagittal cut. Black arrow
indicates coronal suture. 144x C) Sagittal Suture of an 8-week-old wildtype zebrafish, sagittal cut.
Black arrow indicates sagittal suture. 144x D) Cross section of an 8-week old wildtype zebrafish
head, black box indicates sagittal suture. 32x E) Close up of the sagittal suture of an 8-week old,
wildtype zebrafish. 144x. Black arrow indicates sagittal suture.
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Wildtype F2

itgav Mutant F2

itgav Mutant F1

Figure 33. Comparison of a caudal view of wildtype 9-week-old zebrafish to itgav
mutant zebrafishes head sections. Boxes in blue indicate the area that has been magnified
in the bottom row. Wildtype skull is symmetrical and the sagittal suture demonstrates two
bone layers that remain open. Mutant itgav skull are asymmetrical and the sagittal suture
has additional layers of bone. These additional bone layers appear to be causing the
asymmetrical skull deformities seen. The exact mutation in the F1 mutant is not known.
Top row is 32x magnification, while bottom row is at 40x.
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Wildtype F2

itgav F2 mutants

itgav F1 mutants

Figure 34. Comparison of interfrontal suture in wildtype F2s and itgav mutants, caudal view of
the head. Boxes in blue indicate areas that were magnified, represented in the bottom row. Black
arrows indicate the interfrontal suture. Additional bone layers in the interfrontal sutures were seen
present in the wildtype F2s when compared to the itgav mutants. The exact mutation in the F1
mutant is not known. Magnification at 40x.
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Wildtype F2

itgav F2 mutant

itgav F1 mutant

Figure 35. Comparison of the lambdoid suture between wildtype and itgav mutants, sagittal
view of a head section. Black arrow indicates the lambdoid suture on a wildtype 9-week-old
zebrafish. No lambdoid suture is seen present in either itgav mutants. The exact mutation in the
F1 fish is not known. Magnification at 40x.
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Wildtype F2

itgav F2 mutant

itgav F1 mutant

Figure 36. Comparison of the coronal suture between wildtype and itgav mutants, sagittal
view of the head section. Black arrows indicate the coronal suture. The coronal suture of the
wildtype fish is open, while the itgav mutants have additional bone layers and the sutures appear
nearly closed. The exact mutation in the F1 fish is not known. Magnification at 40x.
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Wildtype F2

itgav F2 mutant

itgav F1 mutant

Figure 37. Comparison of the interfrontal sutures between wildtype fish and itgav mutants,
sagittal view of the head. Wildtype fish have a clear, distinctly open interfrontal suture, while
itgav mutants have increased bone formation and abnormal suture development. The exact
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A)

B)

Figure 38. Comparison of the wildtype F2 heart compared to an itgav F2 mutant, caudal
view of the heart. Magnification is at 20x. A) Wildtype heart at 8 weeks of age. Muscle is
pronounced and tightly compacted. The structure resembles a human heart. B) A heterozygous
F2 itgav mutant heart at 8 weeks of age. The heart structure is abnormally shaped, with sparse
muscle.
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Chapter 4: Discussion

The intent behind this thesis was to analyze two nonsyndromic families to see if two
common SNPs, BMP2 and BBS9 helped to explain the synostosis phenotype seen. In addition to
genotyping the SNPs, I also analyzed three candidate genes that were previously identified as
potentially causing the nonsyndromic sagittal craniosynostosis phenotype. To assess the effect
that these three genes had on suture formation, an animal model was selected to carry out testing.
Zebrafish were the preferred model of choice, for their high fecundity, genetic conservation, and
development ex vivo. Transgenic overexpression of bambi was attempted but not created and
CRISPR knockdowns of itgav and slc30a9 were successfully created.
When genotyping for the SNPs associated with CS, it was found that both families CS 27 and CS 14-15, all had the BBS9 risk allele. When BMP2 was genotyped, it was found that CS
14-15 didn’t have the risk allele, but CS 2-7 did. These results do not explain the synostosis
phenotype seen, and it was concluded that the candidate genes found in those families plus the
common SNPs, clearly did not segregate to explain the synostosis seen. As there is no clear
segregation to explain the synostosis, the literature should be watched in order to see if any other
risk alleles or epistatic interactions between genes are found. Whole genome sequencing can
also be attempted to scan for candidate variants as well.
Due to the complex inheritance that is seen in nonsyndromic craniosynostosis, it is
predicted that the disease is polygenic; i.e., caused by mutations in different genes. This is
readily exemplified by an identification of candidate mutations in CS-64 family but a failure to
find the same candidate mutations in the CS-14 family, even though both families presented with
the sagittal synostosis. Further studies will be undertaken with the samples collected through the
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VCU Center for Craniofacial Care, to allow for further sequencing and identification of
candidate mutations.
We have shown that bambia is expressed in the head during development and is heavily
expressed in the skulls, as well as the sagittal suture, of 8-week-old, wildtype zebrafish. Further
analysis of this gene and its association with NSC will be performed by an analysis of its
overexpression in zebrafish. The gene has been shown to interact with BMP2 in bone formation,
which has been suggested to be contributing to the synostosis phenotype. It could be that a
mutation in BAMBI, in combination with a common BMP2 SNP, associated with NSC, could be
causing the phenotype.
Currently, two F2 generations of slc30a9 mutants are in the process of growing up. Once
they reach adulthood they will be genotyped, bone stained, and heads H&E stained. My results
have shown that slc30a9 is heavily expressed in the head during development as well as in 8week-old, wildtype zebrafish. Analysis of the slc30a9 lines will be undertaken and further
studies will be based off the results seen.
A phenotype was found with heterozygous F2 mutants of itgav. This phenotype clearly
affects bone formation, and has been shown to have compressed, asymmetrical skulls as well as
curvature of the spine. In addition to the differences in phenotype seen in the head and spine,
other bodily abnormalities such as differences in heart structures were seen between the F2 itgav
mutants and wildtypes. While not related to CS, these differences should be investigated so
there is a clear picture of what happens when itgav is mutated. To do so, whole body H&E
sections should be performed. It would also be of interest to compare itgav mutants with
wildtype embryos to see if there is increased amounts of bone during the early stages of
development. It would also be of interest to analyze how early these bone differences occur in
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the itgav F2 and wildtype. My results show that itgav is expressed in the head during
development, however it is not expressed or at least not at a detectable level in the zebrafish skull
at 8 weeks of age. This means that itgav could have played a role in the early development of
the skull, however at 8 weeks of age, the gene has been turned off and not expressed. Future
studies should take wildtype head sections at different developmental time periods to test when
the expression of itgav turns off. Further studies of this gene will involve increased numbers for
a phenotypic analysis. In addition, F2’s will be mated together to check if homozygosity in itgav
is viable. It is of interest to note that when a previous mating of two itgav F0’s, no homozygous
(or compound heterozygous) offspring were identified. Even though both parents were mosaic
for itgav mutations, it is expected to see 1 or 2 compound heterozygotes out of the 9 surviving
offspring. Due to the severity of the bone abnormalities seen in itgav heterozygous mutants, it
could be that mutations of both alleles is embryonic lethal. As it has been shown that ITGAV
influences BMP2’s role in osteoblast formation, it could be that together the common risk allele
in BMP2 and a mutation in ITGAV is producing the synostosis phenotype.37 Further studies
could be undertaken to genotype affected human samples to see if there is a connection. If there
is a connection then there should be other mutations in ITGAV that are found in CS affected
families. These mutations in ITGAV, if there is a connection with BMP2 will show that a clear
segregation with the synostosis phenotype and the BMP2 risk allele. It is predicted based on
previous work done on SMAD6 and BMP2, that an ITGAV mutation by itself transfers a risk of
having CS, however when paired with the BMP2 risk allele there will be a high risk of having
CS.23
There is a chance that the combination of candidate mutations in the CS-64 family could
be the cause of sagittal CS. Currently itgav;slc30a9 double mutants are being generated; one

111

such fish died and was bone stained. F2’s of the surviving fish will be bred and phenotypically
analyzed in the future. Once we have generated a transgenic line of bambia-overexpressing fish,
these can be crossed with the itgav and slc30a9 mutants to test the effects of a multigenic
component to synostosis. The SLC30A9 and ITGAV mutations are predicted to decrease protein
stability, overexpression BAMBI with a knockdown in either SLC30A9 or ITGAV should be
explored.
While at least 70% of the human genome has a zebrafish ortholog and 84 % of genes
associated with human diseases has a zebrafish ortholog counterpart, there are substantial
differences between the two genomes.31 Zebrafish had an genome-wide duplication in their
evolutionary history, leading to 26, 206 protein coding genes, which is one of the results for the
two bambi genes (bambia and bambib) found in zebrafish genome.54,59 Due to these noticeable
differences in the genome, zebrafish isn’t a perfect model for the human candidate genes that we
have found. Therefore, to confirm if a synostosis phenotype is seen is caused a candidate gene,
additional studies and sequencing of affected human patients will need to be performed. We
would expect to find additional mutations in a candidate gene in a multitude of CS affected
familes. If additional mutations in that candidate gene is seen in other NSC patients, a strong
case can be made for the candidate gene playing a role in producing the synostosis.
In addition, it is of interest to create the precise mutations seen in the CS-64 family and
introduce them in to zebrafish using CRISPR/Cas9 system. This will allow us to analyze if the
exact mutations seen in the CS-64 family is causing the synostosis phenotype seen.
As there was a heterozygous itgav mutant phenotype that clearly showed an increase in
bone formation and abnormal suture development, it suggests that itgav plays a role in suture
formation. However, no closure of the suture was seen. Since there was no closure, and NSC

112

has already been shown to have been caused by epistatic interactions it could be that there is an
additional modifier gene that when mutated helps produce the phenotype. The TGF-b pathway
has previously been associated with NSC, and itgav plays a role in the beginning of that cellular
pathway. It could be that when itgav is mutated and another gene in the pathway is also mutated,
it causes the synostosis to be produced. BMP2 is something that has been associated with NSC
as well as the TGF-b pathway, and it has been shown to play a role in bone formation with
ITGAV.37 It would be of interest for future studies to mutate itgav and bmp2 in zebrafish to see if
the combination of mutated genes in both produces the synostosis phenotype.
After seeing the phenotype produced when itgav is mutated in fish, I believe that itgav
does have the potential to play a role in causing NSC. While the fish has a severe mutation in
itgav compared to the ITGAV candidate mutation we saw in our affected family, I do still think
that the ITGAV mutation in humans is relevant to the synostosis seen. Mouse model knockouts
of Itgav have not been successful in keeping pups alive to produce fertile, viable adult mice with
the mutation, due to the severity of the phenotypes seen in the mice at birth.38 Previous research
in the literature and my results suggests a severe mutation of the itgav gene produces severe side
effects that are clearly detrimental to the viability of the animal. In addition, the exact mutations
for my F1 itgav mutants are not known, however different levels of severity were seen,
suggesting that different mutations in itgav can lead to variable phenotypes produced, with some
phenotypes being more severe than others.
With evidence suggesting variations seen in the mutant itgav phenotype, I do believe our
candidate ITGAV mutation, is playing a role in producing the synostosis seen in our CS-64
family and there is a reason that there are no other bodily abnormalities seen with the synostosis.
As the ITGAV mutation in the CS-64 family is only a single amino acid change, I speculate that
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the mutation is not serious enough to produce the other vast side effects seen in animal models
when severe mutations of itgav are produced, yet this single change does help produce the
synostosis seen. However, I do not believe that it is acting by itself to produce the phenotype.
As we found that both affected individuals in our CS-64 family had the same ITGAV mutation
plus the BMP2 risk allele, I believe that the ITGAV mutation results in increased bone formation
and suture development, while the BMP2 risk allele accelerates bone formation at the suture
resulting in the premature synostosis seen. ITGAV is suggested to be an important regulator of
bone formation that does not allow for much variety in the gene, due to its conserved
evolutionary importance in a wide variety of different bodily systems, as shown in animal
models.38 It would be of interest to future studies to sequence ITGAV in other affected CS
families to see if more ITGAV mutations are present. These families should then be genotyped
for the BMP2 risk allele to test if there is a clear segregation with the ITGAV mutation and if
those with both mutations have the synostosis phenotype.
To conclude, I propose the candidate gene we found in our CS-64 family for ITGAV in
conjugation with the BMP2 risk allele, has resulted in the sagittal synostosis observed. I propose
that future genotyping studies in affected NSC families will show that mutations in multiple
genes in the TGF-b pathway will be shown to produce a synostosis phenotype, due to epistatic
interaction. I also propose that future genotyping into ITGAV will show that there are various
ITGAV mutations found in affected CS families and upon further inspection some will be found
to have the BMP2 risk allele that clearly segregates with the ITGAV mutation producing the
synostosis phenotype.
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Appendix
Genotyping Zebrafish Protocol:
47.6 ul of H2O and 2.4 ul of 1 M, NaOH are combined in a tube.
Fish are then finclipped and fins are placed in the solution.
The solution is placed in the thermocycler for 10 minutes at 95° C.
5 ul of 1M, Tris, ph 82 is then added to the solution.
Solution is vortexed then stored at -20° C till use.

Raising Zebrafish Protocol:
Embryos are sorted and placed in clean system water. 5 ul of methyl blue is added to the dish.
Embryos are checked daily to clean the dish. After five days, the embryos are moved into the
fish room. They are placed on a diet of baby food until they reach one month of age and then
receive pellet food and brine shrimp.
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